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Abstract 
 
Acoustic cavitation occurs when ultrasound is applied to a liquid. Bubbles are generated, 
oscillate, expand and, when specific criteria are met, implosively collapse. These collapses 
generate hot spots and shockwaves. Hot spots have intense local temperatures (~5,000 K) and 
pressures (~1,000 atm), and a rapid heating and cooling rate (> 1010 K s-1). Shockwaves can 
induce crystallization, i.e., sonocrystallization, or break existing crystals, i.e., 
sonofragmentation in solid-liquid mixtures.  
The sonofragmentation of ionic and molecular crystals is discussed in Chapters 2 and 3. 
When ultrasound was applied to slurries of ionic or molecular crystals, crystal breakage 
occurred not by interparticle collision but by direct interactions between crystals and 
shockwaves. Sonofragmentation rates depended strongly on the strength of the crystal material, 
as described by its Vickers hardness or Young’s modulus. This is a mechanochemical 
extension of the Bell–Evans–Polanyi Principle or Hammond’s Postulate: i.e., activation 
energies for solid fracture correlate with the binding energies of solids. In addition, from 
comparisons of sonofragmentation patterns between ionic and molecular crystals, it was 
confirmed that the sonofragmentation of ionic crystals was more sensitive to changes in 
material hardness than that of molecular crystals. Finally, two possible mechanisms of particle 
breakage via sonofragmentation were suggested: particle breakage from defects formed by 
shock-induced compression-expansion of the initial crystal and particle breakage from defects 
created during shock-induced bending or torsion of the initial crystal.  
In Chapters 4 and 5, the sonocrystallization of pharmaceutical agents having inherently 
low water solubility is discussed. Chapter 4 describes the development of a spray 
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sonocrystallization system. Spray sonocrystallization produced nano-scale carboxyphenyl 
salicylate crystals (c.a. 100 nm) with a narrow size distribution. The crystal size was 
controllable by changing the initial solute concentration. In Chapter 5, carbamazepine crystals 
were produced via various crystallization methods, including spray sonocrystallization. 
Crystal sizes, solubility and dissolution rates were compared among carbamazepine crystals 
generated by five different crystallization methods. Spray sonocrystallization produced the 
smallest crystals and resulted in the most rapid observed dissolution rate in water. 
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Chapter 1  
Introduction 
 
1.1 Acoustic cavitation 
Ultrasound is an oscillating sound pressure wave over a frequency range of 15 kHz to 10 
MHz.1 When ultrasonic waves pass through a liquid with sufficient amplitude, the negative 
pressure exceeds the local tensile strength of the liquid and bubbles are created.2-4 Bubbles are 
typically generated near pre-existing impurities (e.g., gas-filled crevices in dust motes), which 
oscillate and grow during cycles of compression and expansion. When the growing bubbles 
reach a specific size they efficiently absorb energy from ultrasound waves during a single 
compression‒expansion cycle.1, 5-6 This is called the resonant size. The resonant size depends 
on the frequency of the irradiated ultrasound, which is approximately 170 m for a 20 kHz 
ultrasound.1 At the resonant size, bubbles grow rapidly during a single cycle of ultrasound 
waves due to efficient energy absorption. Since bubbles cannot be sustained without 
absorption of energy, they implosively collapse after reaching the resonant size. This process 
is referred to as acoustic cavitation (Figure 1.1).  
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Figure 1.1 Graphical summary of acoustic cavitation. When ultrasound is applied to a liquid, 
acoustic cavitation occurs: bubbles are formed in the liquid, oscillate and expand, and, finally, 
implosively collapse.6  
 
There are both chemical and physical effects of acoustic cavitation. Ultrasonic 
wavelengths in liquid vary from approximately 1 mm to 10 cm, which is much larger than the 
molecular size scale. Thus, the chemical and physical effects of ultrasound do not occur by 
direct interactions between ultrasound and chemical species, but by the process of acoustic 
cavitation.2, 4, 7 The collapse of bubbles produces hot spots, which have intense local 
temperatures (~5,000 K) and pressures (~1,000 atm), and a rapid heating and cooling rate (> 
1010 K s-1),8-11 and shockwaves. Shockwaves have velocities as high as ~ 4,000 m/s and high-
pressure amplitudes of 106 kPa.12  
The physical effects of ultrasound are more diverse in heterogeneous systems (solid–liquid 
systems), than in homogeneous systems. When a bubble collapses near a significantly larger 
surface or particle, the bubble no longer collapses spherically and a high-speed liquid stream 
with a velocity > 100 m/s is generated (i.e., microjet).13-14 The liquid moves toward the surface 
of the solid material, which deforms it or changes its chemical composition.1, 15 Additionally, 
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shockwaves generated from acoustic cavitation cause high velocity collisions between micron-
sized solid particles (i.e., interparticle collisions).16-17 Also, shockwaves can directly interact 
with particles and induce breakage (i.e., sonofragmentation).18 
Sonocrystallization is crystallization induced by ultrasound, and was first report by Alfred 
Loomis in 1927.19 In that report, the author investigated the ultrasonic effects of crystallization, 
among other diverse physical and chemical influences. From the 1950s to the 1970s, 
sonocrystallization was actively studied in the former Soviet Union.20-23 Since that time, 
sonocrystallization of various materials and the modification of diverse experimental 
parameters have been reported.24-26 Since the 1980s, the industrial use of sonocrystallization 
has increased due to advances in equipment, and currently, sonocrystallization is common for 
generating crystals in pharmaceutical and fine chemicals sectors.27-29 Despite considerable 
research, a fundamental understanding of sonocrystallization, especially the mechanism of 
action, remains incomplete.  
 
1.2 Nucleation 
There are two steps in crystallization: nucleation and crystal growth. Molecules in a 
solution coagulate to form nuclei, and grow into visible crystals.30 Nucleation is classified by 
the addition of seed crystals and spontaneity (Figure 1.2).31 Primary nucleation refers to 
nucleation in systems that do not already contain crystals. Primary nucleation can be either 
homogeneous or heterogeneous. Homogeneous nucleation occurs spontaneously, while 
heterogeneous nucleation is induced by foreign surfaces or particles. Secondary nucleation 
refers to nucleation from crystals found in a supersaturated system during crystallization. 
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Figure 1.2 Classification of nucleation.31 
Coagulation and redissolution of molecules or clusters occurs continuously in a 
supersaturated solution with surface excess free energy (ΔGs) and volume excess free energy 
(ΔGv) (Figure 1.3). Surface excess free energy is the excess free energy coupled between the 
surface of a small solid cluster and the bulk of the solid; it is the barrier to formation of the 
surface of a nucleus. Volume excess free energy is the excess free energy between a large 
particle and the solute, and is required for the transition from solute to a nucleus. The overall 
free energy (ΔG) is the sum of the free energies, as described by the following: 
ΔG = ΔGs + ΔGv 
= 4πr2γ +  πr3ΔGν 
where r = the radius of a cluster assumed as a sphere; Gν = the free energy change of the 
transformation per unit volume; and γ = interfacial tension between the developing crystalline 
surface and the supersaturated solution in which it is located. 
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Figure 1.3 Crystallization kinetics. Volume excess free energy (ΔGv) favors aggregation 
whereas surface excess free energy (ΔGs) allows dissolution. Thus, formation of nuclei is a 
compromise between volume and surface term.31 
 
A nucleus forms when a cluster has a higher overall excess free energy than the so-called 
critical free energy (ΔGcrit).  
ΔGcrit =   πγrc2  
A cluster reaches the critical free energy when the radius of the cluster reaches a critical size 
(rc). If the size of a cluster is equal to or greater than the critical size, nucleation occurs, while 
if the size of the cluster is smaller than the critical size, it re-dissolves into the solution. 
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1.3 Effects of ultrasound on nucleation 
1.3.1 Induction time 
Induction time (tind) is the elapsed time between supersaturation and the appearance of 
crystals (Figure 1.4).31 It is composed of three parts, including the relaxation time (tr), stable 
nucleus time (tn) and nucleus growing time (tg). The relaxation time is the time required for 
the crystallized solution to achieve a quasi-steady-state distribution of molecular clusters, 
while the stable nucleus time and nucleus growing time are the times required for the formation 
of a stable nucleus and its growth to a detectable size, respectively. In some systems, especially 
those with a low degree of supersaturation, massive nucleation occurs following a latent period 
(tlp). The concentration of the crystallized solution remains relatively constant during the 
induction time and latent period. Following the latent period, widespread crystal growth occurs 
and the concentration of the solution changes rapidly and significantly. 
 
Figure 1.4 A desupersaturation curve. There is lag time between the point of supersaturation 
(A) and nucleation (B’). Initial nuclei grow until they are a detectable size (B). The 
concentration of the solution remains relatively constant for some time (C) and then it changes 
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Figure 1.4 (cont.) dramatically (D) due to rapid crystal growth. Finally, it reaches the 
equilibrium concentration (E). C* = equilibrium saturation, tn = nucleation time, tind = 
induction time, and tlp = latent period.31 
Ultrasonic irradiation reduces induction time due to the improved micro-scale mixing and 
turbulence caused by acoustic cavitation. When the induction time decreases, the rate of 
appearance of crystals accelerates. Thus, the number of produced crystals increases, while 
their sizes decrease.  
Z. Guo et al. studied the effects of ultrasound on induction time using saturated 
roxithromycin solutions.32 In this study, saturated roxithromycin solutions were mixed with 
water (antisolvent) under ultrasonic irradiation and the induction time was assessed using a 
He–Ne laser recorder. Notably, induction time was reduced when sonocrystallization was 
performed (Figure 1.5). Additionally, the difference in induction time between 
sonocrystallization and stirring crystallization increased as the supersaturated ratio of the 
solution decreased.  
 
Figure 1.5 Influence of ultrasound on the induction time (tind) of roxithromycin solution 
having different supersaturated ratios (S) in presence (▲) and absence (■) of ultrasound.32  
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Those authors also assessed the induction time of BaSO4 under ultrasonic irradiation and 
found that the induction time of sonocrystallization was shorter than that for stirring 
crystallization.33 Furthermore, it was confirmed that sonication with high amplitude ultrasound 
waves decreased induction time more than sonication with low amplitude waves (Figure 1.6). 
 
Figure 1.6 Influence of ultrasound on the induction time (tind) of BaSO4 solution having 
different supersaturated ratio (S). The amplitude of 750W ultrasonic processor modified as 0% 
(♦, no ultrasound), 21% (■), 31% (▲), 41% (x), 51% (*), and 61% (●).33  
 
1.3.2 Metastable zone width 
The metastable zone width (MZW) is the area between an equilibrium saturation curve 
and the experimentally observed supersaturation point at which nucleation occurs 
spontaneously (Figure 1.7).31 For the generation of crystals, the status of a solution changes 
from stable to metastable to labile (unstable). There are several ways to generate crystals, 
including cooling (ABCD line), evaporation or addition of an antisolvent (AB’C’ line), a 
combination of cooling and evaporation, or cooling and the addition of an antisolvent (AB’’C’’ 
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line). 
 
Figure 1.7 Solubility-supersaturation diagram. Solid line is a solubility curve of a solution. 
Dashed line is a supersaturation curve which represents temperatures and concentrations at 
which uncontrolled spontaneous crystallization occurs.31 
 
When a solution is ultrasonically irradiated, the MZW decreases. During 
sonocrystallization, gas-filled crevices surrounding dust motes behave as new nucleation sites 
causing an increase in the rate of nucleation.30, 34 Additionally, microscale mixing and 
turbulence improves from the collapse of bubbles during sonocrystallization.35-38 They 
accelerate diffusion of solutes and increases the nucleation rate. Due to such increased 
nucleation sites and improved mixing efficiency, sonocrystallization reduces the MZW. 
The effects of ultrasound on the MZW were confirmed during the crystallization of p-
aminobenzoic acid (PABA).39 Cooling crystallization of PABA was performed at a constant 
cooling rate of 1 °C/min during sonication or with stirring. The nucleation temperature was 
determined by detecting the appearance of the first crystals becoming visible to the naked eye. 
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As shown in Figure 1.8, nucleation occurred at lower levels of saturation during sonication 
compared to stirring. 
 
Figure 1.8 Effect of ultrasound on metastable zone width of p-aminobenzoic acid 
crystallization. For sonocrystallization, 20 kHz and 2.1 W/cm2 of ultrasound was used. For the 
unsonicated cases, a magnetic stirring bar was used to stir the solution at 300 rpm.39 
 
Another example of a reduction in MZW under sonication is the antisolvent crystallization 
of benzoic acid.40 A saturated benzoic acid solution was prepared using absolute ethanol, and 
mixed with water (antisolvent) by either conventional magnetic stirring or ultrasonic 
irradiation at room temperature. As shown in Figure 1.9, MZW decreases significantly on 
ultrasonic irradiation of the benzoic acid solution. 
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Figure 1.9 Simulated and experimental results of MZW change of benzoic acid with various 
addition rates of antisolvent (a) with stirring (a magnetic bar, 400 rpm) and (b) under 
sonication (20 kHz, 8 W/cm2). For each graph, the Eq_conc line is solubility curve of benzoic 
acid.40  
 
1.3.3 Critical excess free energy 
Ultrasound promotes nucleation by reducing the critical excess free energy (ΔGcrit). When 
ultrasound is irradiated to a solution, bubbles are generated.2-4 At the bubble-solution interface, 
half a solute molecule is solvated by the solvent, while the other half is not due to contact with 
the bubble. Such contacts decrease the solvation rate. Re-dissolution of the solute molecule is 
then prevented, increasing the coagulation of molecules in the solution.41 Thus, the critical 
excess free energy (ΔGcrit) for nucleation is reduced (Figure 1.3), while the nucleation rate 
increases.30-31 
 
1.3.4 Interparticle collisions and sonofragmentation 
Ultrasound increases the rate of secondary nucleation by affecting the number of 
secondary nucleation sites. Under ultrasonic irradiation, the crystals generated from primary 
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nucleation collide or interact with shockwaves.42-44 Due to these occurrences, pre-existing 
crystals are fragmented and become sites of secondary nucleation.34, 45  
Chow et al. investigated sonocrystallization of ice crystals in sucrose solution, which 
formed ice dendrites (Figure 1.10).46-48 Primary nucleation produced the ice dendrites, which 
subsequently fragmented due to continuous sonication. During prolonged sonication, 
secondary nucleation occurred around the fragmented crystals and cavitation spots. From 
corresponding images of these events, it was confirmed that ultrasound affected primary and 
secondary nucleation events. 
 
Figure 1.10 Optical micrographs of sonocrystallization and sonofragmentation of ice 
dendrites in a 15 wt% sucrose solution. (a) primary nucleation and crystal growth (no 
ultrasound), (b) flow patterns and breakage of ice dendrites after 1.36 seconds of sonication, 
(c) sonofragmentation of ice crystals after 2.38 seconds of sonication, and (d) secondary 
nucleation and crystal growth after 17.38 seconds of sonication.46 
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1.4 Advantages of sonocrystallization 
1.4.1 Reduction of crystal size  
Sonocrystallization is an effective method to generate small crystals. Induction time, MZW 
and excess free energy are reduced under sonication. Additionally, interparticle collisions and 
sonofragmentation can occur during sonication. Owing to these effects, rates of primary and 
secondary nucleation increase and sonocrystallization produces large numbers of small 
crystals. 
Sonocrystallization can produce smaller crystals than other methods, and recently, Gogate 
et al. investigated the effects of ultrasound on crystal size using mefenamic acid.49 Saturated 
mefenamic acid solutions were prepared at 60 °C and cooled to room temperature. During the 
cooling process, either 20 kHz and 30 W/cm2 of ultrasound was applied for 30 minutes, or 
stirring was performed at 200 rpm using a magnetic bar. Figure 1.11 shows the significant 
reduction in crystal size that was observed when the solution was sonicated.  
 
Figure 1.11 Effect of ultrasound on crystal size of mefenamic acid. (Left) optical microscopic 
images of mefenamic acid crystals generated by cooling crystallization (a) without sonication 
(stirring) and (b) with sonication. Scale bars are 100 and 20 μm, respectively. (Right) Crystal 
size distribution of mefenamic acid.49 
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1.4.2 Reduction of crystal size distribution 
Sonocrystallization produces crystals with a narrow size distributions. Acoustic cavitation 
causes vigorous mixing and turbulence in a solution, which prevents crystals from 
agglomerating. Also, crystals generated via sonocrystallization are unaffected by the size of 
the seed crystals. During seed crystallization, the size range of the seed crystals greatly impacts 
the size distribution of the final crystals. However, since sonocrystallization does not require 
seed crystals, there is no effect of the size of the starting crystals.    
Changing ultrasonic conditions controls the crystal size distribution. Paracetamol was used 
to assess the effects of ultrasonic waves on crystal size distributions.50 Antisolvent 
crystallization was performed using saturated paracetamol and water under sonication, and the 
intensity and frequency of the ultrasound was modified. From the comparisons between 
Figures 1.12 and 1.13, ultrasound reduced the size distribution of paracetamol crystals. 
Additionally, when the intensity and frequency of the irradiated ultrasound increased, the size 
distribution of crystals reduced (Figure 1.13). 
 
Figure 1.12 Crystal size distribution and optical microscope image of paracetamol generated 
via antisolvent crystallization with stirring (800 rpm).50 
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Figure 1.13 Crystal size distributions of paracetamol crystals produced via antisolvent 
sonocrystallization.50  
 
1.4.3 Controllable polymorphism 
Polymorphisms can be effected by sonocrystallization. Polymorphism is the ability of a 
solid material to exist in more than one form or structure.51 Polymorphs have different 
stabilities under certain conditions, and the preferred form depends on the condition in which 
the polymorphs are formed or stored. It is unknown how ultrasound controls the polymorphism 
of a material.52-54 
Sonocrystallization generally converts crystals from their kinetically favored form to one 
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that is thermodynamically favored. A typical example is that of calcium carbonate, which 
exists in three different forms, including calcite (the most stable form under ambient 
conditions), aragonite (metastable) and vaterite (the least stable form).55 Without sonication, 
vaterite, which is the kinetically favored form, was generated. However, the percentage of 
calcite, which is the thermodynamically favored form, increased as sonication time or intensity 
increased (Figure 1.14).55 Thus, more intense or extended periods of sonication might promote 
the ground state polymorph due to the improved mass transport and local heating from acoustic 
cavitation.   
 
Figure 1.14 Variation of composition of CaCO3 polymorphs under sonication (20 kHz): (a) 
the effect of intensity of ultrasound with 30 minutes of sonication, and (b) the effect of 
sonication time with 13 W/cm2 of sonication.55 
 
Conversely, sonocrystallization can sometimes produce a less thermodynamically stable 
polymorph. Paracetamol exists as either form I (stable) or form II (metastable), and given the 
difference in stability between the forms, form II has higher solubility.56 When a 
supersaturated paracetamol solution was cooled without sonication, plate-like crystals (form 
I) were generated. However, with sonication, needle-like crystals (form II) were formed 
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(Figure 1.15). The generation of less stable forms from sonocrystallization has been reported; 
however, until now, no clear explanations were provided.50, 56-60 
 
Figure 1.15 Optical microscopic images of paracetamol polymorphs: (a) form I produced by 
stirring (150 rpm), (b) form II generated via ultrasonic irradiation with 28 kHz, and (c) form 
II crystallized via ultrasonic irradiation with 45 kHz.56 
 
1.5 Various parameters of sonocrystallization 
1.5.1 Frequency of ultrasound 
Changes in ultrasound frequencies affect the bubble dynamics.61 At low ultrasonic 
frequencies, cavitation bubbles experience positive and negative pressure ultrasound waves 
for extended periods of time because wavelengths increase as frequencies decrease. Thus, the 
bubble oscillation amplitude is large since the size of the bubble differs substantially during 
compression and expansion periods.62-63 Conversely, high ultrasonic frequencies shorten the 
wavelength of the ultrasound and the lifetime of the cavity is reduced. There are many 
cavitation bubbles and the power of collapse from each bubble is weak.64-65 It is very difficult, 
however, to compare different frequencies due to changes in the number of cavitating bubbles, 
which is highly dependent on the specific apparatus used. 
Koda et al. produced liposomes under ultrasonic irradiation and assessed the effects of 
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irradiation frequency on their size. Three different frequencies (43, 143 and 480 kHz) were 
applied at a fixed intensity (8 W/cm2). It was observed that the size of the liposomes decreased 
as the sonic frequency decreased, due to changes in bubble dynamics (Figure 1.16).66  
 
Figure 1.16 The effect of frequency of ultrasound on crystal size of liposome. The ultrasonic 
power was 8 W/cm2, and the frequencies were 43 kHz (○), 133 kHz (□), and 480 kHz (◊), 
respectively.66  
 
Another study investigated the effects of the frequency of ultrasound waves on MZW.67 
Cooling crystallization of paracetamol was tested without or with ultrasonic irradiation at 
multiple frequencies (from 41 to 1,140 kHz), and the MZW was calculated as the difference 
between the nucleation temperature and the saturation temperature. When the frequency of the 
ultrasound increased, the MZW decreased (Figure 1.17). 
19 
 
 
Figure 1.17 The effect of ultrasound frequency on reduction of MZW of paracetamol. The 
amount of reduced MZW is the difference of MZW of cooling crystallization of paracetamol 
without and with sonication (8 W/cm2). The cooling crystallization and cooling 
sonocrystallization experiments were performed at least three times for each frequency. The 
dots are the average reduction of MZW and the error bars are the standard deviations.67  
 
1.5.2 Intensity of ultrasound 
When ultrasound intensities increase, the size of generated crystals decreases. Increased 
sonication intensities cause more vigorous microscale mixing and turbulence, which causes 
solutes to diffuse more rapidly.68 Due to the accelerated diffusion of solute, induction time and 
MZW are reduced and the nucleation rate increases. Also, the vigorous microscale mixing and 
turbulence helps to prevent crystals from agglomerating.69 The effect of ultrasound intensity 
was investigated during sonocrystallization of roxithromycin.70 The intensity was adjusted 
from 5 to 15 W/cm2, which caused the average crystal size to decrease (Figure 1.18).  
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Figure 1.18 The effect of intensity of ultrasound on crystallization of roxithromycin: (a) 
cumulative crystal size distributions and (b) SEM images of roxithromycin with different 
sonication intensities. For all sonication experiments, the solution was sonicated at 22.5 kHz 
for 10 minutes. Scale bars are 100 μm.70 
 
1.5.3 Sonication time 
As sonication time increases, crystal sizes decrease and become more uniform. For short 
sonication time, solution and precipitants are not mixed uniformly.62 The generated crystals 
from the solution are irregularly shaped and various sized. Thus, prolonged sonication time 
improves mixing and prevents crystals from aggregating.71-72 Kougoulos et al. investigated 
the effects of sonication duration on crystal size using adipic acid and found a significant 
difference in crystal size according to whether sonication was applied or not (Figure 1.19).73 
Furthermore, crystal size was reduced as sonication duration increased. As we will see, this is 
often due to sonofragmentation of the crystals formed. 
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Figure 1.19 Effect of sonication time on partice size and size distribution of adipic acid. For 
sonication experiments, the adipic acid solution was sonicated at 20 kHz and 8.5 W/cm2. For 
the control experiment, stirring was performed with a magnetic stirring bar (200 rpm).73 
 
1.5.4 Types of ultrasound generator and configurations for sonocrystallization 
Multiple types of ultrasonic generators exist and provide many different experimental 
configurations for sonocrystallization. Ultrasound generators are typically ultrasonic baths, 
horns and plate transducers (Figure 1.20). 
 
Figure 1.20 Different types of ultrasound generators: (a) ultrasonic bath,74 (b) ultrasonic 
horn,75 and (c) ultrasonic plate transducer.76  
 
Sonicating baths are standard laboratory equipment and are typically used to disperse particles 
22 
 
in liquid. Such sonicators are easily accessed, but are only available in batch configurations.77-
78 Ultrasonic horns are also used to perform sonocrystallization and offer batch or flowing 
configurations (Figure 1.21).40, 68, 79-83  
 
Figure 1.21 Configurations of sonocrystallization with an ultrasonic horn: (a) batch 
crystallization68 and (b) flow crystallization of calcium carbonate.82 
 
For flowing configurations, it is necessary to use specialized crystallization cells and 
additional equipment, such as a peristaltic pump for circulation. However, flowing 
configurations produce crystals continuously if the solution is injected continuously. Another 
type of ultrasound generator is the plate transducer, which generates a wide range of ultrasound 
frequencies. It is essential for sonocrystallization when high frequencies (> 100 kHz) are 
required.84 With the ultrasonic plate transducer, a batch configuration is used for 
crystallization. 
 
1.6 Applications 
1.6.1 Pharmaceutical agents 
Sonocrystallization is used widely to produce pharmaceutical agents (PAs), since it can 
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control crystal sizes, distributions, and polymorphisms.24, 27-29 Reductions in PA size increase 
the dissolution rate and solubility, especially for nanocrystals.85-88 Also, control of 
polymorphisms decreases the probability of side effects.89-90 For PAs, control of such 
properties (i.e., size and polymorphism) is important because they directly affect delivery to 
target organs and work to treat a disease. In fact, multiple PAs, including acetylsalicylic acid, 
paracetamol, phenacetin, carbamazepine, etc., have been generated via sonocrystallization to 
decrease size and size distributions, and/or to control polymorphism (Figure 1.22).50, 56, 67, 69, 
91-94   
 
Figure 1.22 Microscopic images of APs generated by sonocrystallization. Optical microscopic 
images of (a) acetylsalicylic acid91 and (b) paracetamol.50 SEM images of (c) phenacetin69 and 
(d) carbamazepine.92 
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1.6.2 Nanoparticles and nanostructures 
Sonocrystallization is used to generate nanocrystals, since it is an effective method for 
producing small particles.95-97 Qian et al. reported ultrasonic irradiation as a new method for 
generating zinc oxide nanocrystals.98 The conventional method was time consuming, taking 2 
days; however, sonication (20 kHz), generated nanocrystals in 3 minutes. Moreover, 
nanocrystals were formed, using ultrasonic irradiation without the addition of heptane, in 25 
minutes (Figure 1.23).  
 
Figure 1.23 Characterizations of zinc oxide nanocrystals produced by sonocrystallization: 
particle size distribution, electron diffraction pattern and TEM images.98 
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It is possible to produce a variety of nanostructures via sonocrystallization. Li et al. 
produced nanofibers and fibrillar networks using ultrasonic irradiation.99 N-lauroyl-L-
glutamic acid di-n-butylamide (GP-1) were dissolved in octanol or propylene glycol at 120 ◦C 
and quenched to room temperature in an ultrasonic water bath (35 kHz, 1–4 W/cm2) for 0–2 
min. Using sonication, the product was a nanofiber network structure and without sonication, 
spherulitic particles were formed (Figure 1.24). The network structure exhibited an enhanced 
storage modulus and gelation capability compared to the spherulitic particles. 
 
Figure 1.24 GP-1 nanostructures generated without sonication or with sonication: SEM 
imagers of GP-1 (a) spherulitic structures produce without sonication and (b) 3D 
interconnected fiber network structures with 1 minutes of sonication, and (c) storage modulus 
of the 2 wt % GP-1/PG gels formed without ultrasound (□) and with ultrasound (■), 
respectively. Scale bars are 500 nm.99 
 
Hayward et al. reported on the generation of perylene diimide (PDI) nanowires using 
sonocrystallization. PDI and poly(3-hexylthiophene) were dissolved in 1,2-dicholorobenzene 
at 120 ◦C and cooled to 20 ◦C with or without sonication.100 Notably, sonocrystallization 
produced narrower, straighter and less agglomerated PDI nanowires than the cooling 
crystallization without sonication (Figure 1.25 Left). The relatively good control of 
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sonocrystallized nanowire sizes allowed for the preparation of smooth films (Figure 1.25 
Right). 
 
Figure 1.25 (Left) SEM images of PDI nanowire produce by (a) cooling crystallization 
without sonication and (b) sonocrystallization. For the sonocrystallization, the PDI solution 
was irradiated with 35 kHz of ultrasound for 2 hours. (Right) AFM images of PDI nanowire 
films.100 
 
1.7 Sonofragmentation 
In a liquid-solid mixture, acoustic cavitation causes various physical phenomena. If a 
bubble grows near a solid particle larger than the resonant size of the bubble, the bubble is 
deformed due to the asymmetric environment.1, 6 This asymmetry causes the bubble to collapse 
asymmetrically, and a fast-moving stream of liquid (i.e., microjet) is formed.13-14 The microjet 
moves toward the solid particles and causes surface deformation or changes in the chemical 
composition of the surface.1, 15  
When solid particles in the mixture are smaller than the resonant size of the bubble, the 
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shockwave that is generated by acoustic cavitation causes interparticle collisions.16-17, 101 Also, 
shockwaves interact directly with solid particles, causing sonofragmentation.18, 102-103 
Interparticle collisions and sonofragmentation affect the average particle size and size 
distribution, both by reducing the size of existing crystals and creating secondary nucleation 
sites.104  
The effect of the shockwaves generated by acoustic cavitation in liquid-solid systems 
depends on the type of solid in the system. When slurries of metal powders were irradiated 
using ultrasound, interparticle collisions occurred.16-17 The velocity of the colliding particles 
was sufficient to cause intense localized heating, plastic deformation, spot-welding and 
melting (Figure 1.26) of various low-melting point metals (e.g., Zn, Ni, Co, Mo). However, 
high-melting point metals (e.g., W) were not affected to the same extent.  
 
Figure 1.26 SEM image of zinc particles after sonication. 20 wt% of zinc slurry was sonicated 
by an ultrasonic horn (20 kHz and 50 W/cm2) for 30 minutes. Localized melting was caused 
by high-velocity interparticle collisions and particles were agglomerated.16  
 
Sonication of molecular crystals causes sonofragmentation by means of direct interactions 
between particles and shockwaves. Suslick et al. explored the sonication of an aspirin slurry 
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under multiple experimental conditions.18 They suggested four possible mechanisms of 
particle breakage under sonication, including interparticle collision, particle‒horn collision, 
particle‒wall collision and direct interaction between particles and shockwaves (i.e. 
sonofragmentation). As shown in Figure 1.27, interparticle collisions rarely affect particle 
breakage. Additionally, particle‒horn and particle‒wall collisions were negligible contributors 
to fragmentation. Thus, the authors concluded that direct interactions between particles and 
shockwaves were the main causes of fragmentation. 
 
Figure 1.27 Effect of quantity of particle loading on final particle size after sonication for 10 
seconds. Ultrasound was 20 kHz and 5.5 W/cm2. All masses were dispersed in 5 ml of 
dodecane.18 
 
1.8 Conclusion  
Since the 1920s, when sonocrystallization was first discovered, there have been numerous 
studies on sonocrystallization investigating modification of control variables and test materials. 
Sonocrystallization has been developed for use in diverse industrial fields, including 
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pharmaceuticals. However, there are still open questions, such as a basic understanding of the 
mechanism of sonocrystallization and sonofragmentation. 
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Chapter 2 
Sonofragmentation of ionic crystals 
 
2.1 Introduction 
Mechanochemical effects change solid particles physically and chemically under 
mechanical action.1-4 This includes both chemical effects when surfaces of materials are 
rubbed or when solids are broken.5-7 There are many ways of inducing mechanochemistry in 
materials, including trituration, grinding, milling and ultrasound.8-10 When mechanical actions 
are applied to solids, fracture can occur, but our fundamental understanding of the nature of 
the breakage of solids as a function of their chemical and mechanical properties remains 
limited.  The fragmentation of powders in liquid slurries, especially, has received relatively 
little attention.11-12 In this chapter, it was examined fundamental experiments on the 
fragmentation of ionic crystals during sonication of slurries and gained new insights on the 
mechanism of such sonofragmentation. 
When a liquid is irradiated with high intensity ultrasound, acoustic cavitation occurs:  i.e., 
bubbles form, oscillate, grow, and, under certain conditions, implosively collapse; this 
collapse can generate intense local heating, with hot spots created transiently with 
temperatures of <5000 K, pressures of Kbar, and shockwaves launched into the liquid.13-16 If 
a bubble collapses near an extended solid surface (i.e., several times the size of the bubble), 
the collapse becomes asymmetric and a fast-moving stream of liquid (i.e., microjet) impinges 
on the solid surface.17-19 In contrast, microjets do not form in slurries with fine powders (e.g., 
particles less than the bubble diameter), but cavitation still occurs, and shockwaves are formed.  
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The effect of ultrasound on liquid–solid systems depends on the type of materials sonicated. 
For example, when slurries of malleable powders (e.g., softer metals) were irradiated with 
ultrasound, interparticle collisions caused surface deformation, agglomeration, and a change 
in the chemical composition of the particle surface.20-25 In contrast, sonication of slurries of 
brittle materials (specifically, molecular crystals) caused fragmentation of the crystals through 
direct interactions between crystals and shockwaves,26 which is a major component of 
sonocrystallization of active pharmaceutical ingredients (APIs).27-29 While previous studies 
have examined the effects of control variables (e.g., acoustic power density, frequency, liquid, 
etc.) on particle fragmentation,30-34 there is only one report that examines the influence of the 
material properties of solids on their fragmentation under ultrasonic irradiation, and that is 
limited to polymeric solids.35  
For ionic and molecular crystals (particularly for APIs), there are a few articles that 
examine the relationship between the mechanical properties of the particles and their breakage 
under dry milling or particle impaction.36-38  Hardness and elasticity are two of the most 
relevant material properties related to fragmentation. There are several ways to measure the 
hardness of a material, but the Vickers test is the most common.39 The Vickers hardness (Hv) 
of a material is defined by the degree of deformation of the surface by a diamond indenter at 
a given applied force. The Vickers hardness of alkali halides has been measured 
systematically.40-43 The elasticity of materials is quantified by Young’s modulus (E): stress 
(force per unit area) vs. strain (proportional deformation). For the alkali halides, Young’s 
modulus has also been measured.44  
In this study, six different alkali halides, having different Vickers hardness and Young’s 
modulus values, were used to investigate the sonofragmentation patterns of ionic crystals. 
Various parameters, including the crystal size and control variables, were studied to determine 
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their effect on the fragmentation of alkali halides particles. In addition, the mechanism of 
sonofragmentation of ionic crystals was examined. 
 
2.2 Experimental 
2.2.1 Materials  
Lithium chloride, sodium chloride, sodium bromide, potassium chloride and potassium 
bromide were purchased from Fisher Scientific and used as-received, unless otherwise 
indicated. Sodium fluoride (Sigma-Aldrich) was recrystallized in nanopure water (i.e., water 
deionized to >18 MΩ·cm resistance, scrubbed for organics, and passed through a 0.45 μm 
filter with a Barnstead NANOpure®  ultrapure water purification system). Dodecane, decane, 
octane, heptane, and tetradecane were purchased from Sigma-Aldrich and used as-received. 
Silicone oils were Dow Corning 200 fluid®  100 and 350 cSt. 
 
2.2.2 Sonofragmentation experimental setup  
10 ml of dodecane was added to 15 mg of alkali halide. The slurry was allowed to thermally 
equilibrate at 18 °C for 5 minutes in a temperature-controlled water bath (Isotemp 1006S). 
This mixture was sonicated with an exponential ultrasonic horn (Sonics and Materials VCX-
750, 20 kHz, 1 cm2 Titanium tip, 10 W/cm2) for different times. At 20 kHz, the maximum 
diameter of a cavitating bubble before collapse is ~ 150 μm.45 All sonication experiments were 
performed using a duty cycle of 2 sec on and 8 sec off pulse cycle to reduce temperature 
variation. For all cases, steady state temperatures during sonication were 25 °C. Sonication 
times are reported as the total time exposed to ultrasound.  
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2.2.3 Sample preparation of four groups of sodium bromide having different crystal size  
In order to check the effect of initial crystal size, a sonic sifter (Advantech Manufacturing, 
Berlin, WI) was used with various sieves (mesh opening sizes 53, 106, 250 and 500 μm) to 
separate batches of sodium bromide based on their size. The sonic sifter was used for 5 minutes. 
Crystals that were not sieved by the sifter were removed from the sieve. The sieved crystals 
were collected and sieved again with same intensity and time. This process was done total 4 
times for each group of sodium bromide. 
 
2.2.4 Effect of vapor pressure 
To study of the effect of vapor pressure, 15 mg of potassium chloride was used in 10 mL 
of various unreactive organic liquids. All other experimental conditions were same as 
fragmentation experiments of various alkali halides that are described above. Heptane, octane, 
decane, and tetradecane were used as the slurry liquids. Each slurry was sonicated for 140 
seconds. 
 
2.2.5 Effect of viscosity 
Dodecane and Dow Corning 200 Fluid (100 cSt) were mixed and viscosities of the 
mixtures were measured by Cannon-Fenske routine viscometer (Cannon Instrument Company, 
size 100, 150, 200 and 300) at 25 °C in a temperature-controlled water bath (Isotemp 1006S). 
The 160 cSt liquid was made from a mixture of Dow Corning 200 Fluid (100 cSt) with Dow 
Corning 200 Fluid (350 cSt). 15 mg of KCl was added to each of seven mixtures with 
viscosities ranging from 0.1 to 160 cSt, and sonicated for 140 seconds. All other experimental 
conditions were same as sonofragmentation experiments of various alkali halides described 
above. 
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2.2.6 Mechanism studies: interparticle collisions, particle–wall decoupling and particle–
horn decoupling 
Particle loading experiments were explored with various amounts of potassium chloride 
(from 5 to 760 mg) added to 10 mL dodecane. Sonication time was 140 seconds and the steady 
state temperature during sonication was 25 °C. 
Particle–wall decoupling experiments were performed with a latex membrane (Trojan™ 
non-lubricated condom) under ultrasonic power ranging from 5 to 40 W/cm2. The latex 
membrane contained a slurry of 15 mg of potassium chloride and 10 ml of dodecane, and the 
reactor contained 10 ml of dodecane (Figure 2.9b); the control comparison used 30 mg 
potassium chloride in 20 mL of dodecane (Figure 2.9a). Sonication time was 140 seconds and 
the steady state temperature during sonication was 25 °C.  
Particle–horn decoupling experiments were investigated in an opposite way of the crystal-
wall decoupling experiments. The latex membrane contained 10 ml of dodecane, and the 
reactor contained 15 mg of potassium chloride and 10 ml of dodecane (Figure 2.9c); the 
control comparison used 30 mg potassium chloride in 20 mL of dodecane (Figure 2.9a). 
Potassium chloride slurries were sonicated for 140 seconds with ultrasonic power ranging 
from 5 to 40 W/cm2. The steady state temperature during sonication was 25 °C.  
 
2.2.7 Characterization 
An aliquot of sonicated slurry was removed using a disposable pipette for analysis by 
optical microscopy (Zeiss Axioskop optical/fluorescence microscope). The micrographs were 
captures using a Cannon PC1015 digital camera mounted to the microscope. Crystal size 
analysis with optical microscopic images was performed using Image-J software (National 
Institutes of Health, Bethesda, MD, USA). Approximately 200 particles were measured for 
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each experiment. Data fitting was performed using OriginPro 8.5 software (OriginLab, 
Northampton, MA, USA). 
 
2.3 Results and discussion 
2.3.1 Sonofragmentation of ionic crystals 
Alkali halides were fragmented under ultrasonic irradiation (Figure 2.1) and their rates of 
fragmentation shown in Figure 2.2. The particle size decreases exponentially with length of 
time of sonication.   
 
Figure 2.1 (cont.) 
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Figure 2.1 Optical micrographs of alkali halides before and after sonication. (a) Sodium 
fluoride before sonication and (b) after sonication 900 seconds, (c) Lithium chloride before 
sonication and (d) after sonication for 360 seconds, (e) Sodium chloride before sonication and 
(f) after sonication 310 seconds, (g) sodium bromide before sonication and (h) after sonication 
for 140 seconds, (i) potassium chloride before sonication and (j) after sonication for 140 
seconds, (k) potassium bromide before sonication and (l) after sonication for 90 seconds. Each 
slurry contained 0.2 wt% of alkali halide in dodecane and was sonicated by using a titanium 
horn (10 W/cm2 and 20 kHz). 
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Figure 2.2 Fraction of initial crystal size versus sonication time for various alkali halides. 
Slurries containing 0.2 wt% of the alkali halides in dodecane were sonicated using a titanium 
horn (10 W/cm2 and 20 kHz). Solid lines are exponential fits to the data. Standard deviation 
of each data point is less than 4 % of its average value. 
 
The strength of ionic bonding in the alkali halide crystals increases, of course, for 
composed of smaller cations and anions, e.g., NaF is harder than KBr. Among the alkali 
halides, increased Vickers hardness and Young’s modulus values requires longer sonication 
times to reach half the initial crystal size (Table 2.1). When the sonication time is normalized 
by Vickers hardness or Young’s modulus, all values for fraction of initial size are distributed 
near a master line (Figure 2.3). That is, the rate of fragmentation monotonically decreases with 
increasing Vickers hardness or Young’s modulus. The quantitative relationship between 
hardness or elasticity and rate of fragmentation is clear (Figure 2.3), but its origins are 
complicated especially by the critical factor of defect concentration, which will affect the 
mechanical strength and other properties of the materials.46-47  
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Table 2.1 Vickers hardness (Hv), Young’s modulus (E), and sonication time necessary to halve 
the initial crystal size (τ1/2) of alkali halides.* 
Alkali halide Hv (GPa) E (GPa) τ1/2 (sec) Initial crystal size (μm) 
NaF 0.626 77.5 900 500 
LiCl 0.243 49.8 360 580 
NaCl 0.216 37.3 310 340 
NaBr 0.129 29.7 140 490 
KCl 0.128 26.5 140 420 
KBr 0.098 22.3 90 310 
*Determinations of Hv
40, 43
, E
44 and τ1/2 were made on single crystals of the alkali halides. RSD 
of the initial crystal sizes were ~14%. 
 
 
Figure 2.3 Relationship between rate of sonofragmentation and either Vickers hardness or 
Young’s modulus.  (a) log Vickers hardness (Hv) vs. log time necessary to halve the initial 
crystal size (τ1/2); and (b) log Young’s modulus (E) vs. log time necessary to halve the initial 
crystal size (τ1/2). Linear fitting was applied. Standard deviation of each data point is less than 
4 % of its average value. 
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2.3.2 Effect of initial crystal size 
For these studies, it was important to establish any consequences of variation in the initial 
crystal size on sonofragmentation. Sodium bromide was chosen as a test sample and examined 
at initial crystal sizes ranging from 510 µm down to 150 µm (Figure 2.4), isolated by sieving 
using a sonic sifter (Advantech Manufacturing, Berlin, WI). As shown in Figure 2.5, initial 
crystal size had no effect on the rates of fragmentation of alkali halides over the range 
examined. 
 
Figure 2.4 Crystal size distributions of sodium bromide (a) without sieving, (b) sieved by 
sonic sifter (Advantech Manufacturing, Berlin, WI), mesh openings 500 and 250 μm, (c) 
sieved by sonic sifter, mesh openings 250 and 106 μm, and (d) sieved by sonic sifter, mesh 
openings 106 and 53 μm). 
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Figure 2.5 Effect of initial crystal size on fragmentation of sodium bromide. A slurry 
containing 0.2 wt% sodium bromide in 10 mL dodecane was sonicated using a titanium horn 
(10 W/cm2 and 20 kHz). The average particle sizes for each group are given in the key. 
Standard deviation of each data point is less than 6 % of its average value. 
 
2.3.3 Effect of liquid vapor pressure 
We also studied various control variables to determine their effect on the rate of 
fragmentation, specifically liquid vapor pressure, viscosity, and slurry loading. Vapor pressure 
of the slurry was one of control variables examined in this study. When a bubble collapses, 
the mechanical energy of the expanded bubble before collapse is converted into thermal and 
chemical energy of the bubble contents, i.e., the sonochemical hot spot.15, 48 High vapor 
pressure of polyatomic molecules inside the bubble dramatically decreases the effective 
temperatures formed in the hot spot both through endothermic bond dissociation of the 
polyatomic vapor and through the decrease in the polytropic ratio (i.e., the distribution of 
energy into molecular rotations, bond vibrations, and translations).49-50 Thus, different solvent 
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vapor pressures might cause different rates of particle fragmentation. To test this hypothesis, 
several organic liquids were used to prepare various potassium chloride slurries. There was no 
change in the fraction of initial crystal size (Figure 2.6) as liquid vapor pressure increased 
from about 0.01 to 50 Torr. Thus, the vapor pressure of the slurry did not affect fragmentation 
of alkali halides crystals. While vapor pressure dramatically affects the temperature reached 
inside bubbles during cavitational collapse,49-51 vapor pressure does not affect either the total 
mechanical energy of the bubble before the collapse or the bubble rebound that generates the 
shock wave launched into the liquid.25, 28, 52 
 
Figure 2.6 No significant effect of vapor pressure is observed on the rate of fragmentation of 
potassium chloride. A 0.2 wt % of potassium chloride slurry in 10 mL of an unreactive organic 
liquid was sonicated for 140 seconds using a titanium horn (10 W/cm2 and 20 kHz).  
 
2.3.4 Effect of viscosity 
Viscosity may also affect the rate of fragmentation by changing relevant factors, such as 
the number of cavitating bubbles, bubble dynamics, drag on moving particles, and shockwave 
propagation.13, 53 Dodecane and Dow Corning 200 Fluid (i.e., silicone oil) are miscible and 
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were combined to prepare solutions of various viscosities (Figure 2.7). Slurries of the mixed 
liquids and potassium chloride were sonicated, and the effect of viscosity on fragmentation 
was investigated. As the viscosity increased, the rate of potassium chloride fragmentation 
decreased, as expected (Figure 2.8). Indeed, for liquid viscosity greater than ~100 cSt, no 
sonofragmentation was observed. 
 
Figure 2.7 Viscosity measurements of dodecane-silicone oil mixtures. The first data point is 
viscosity of dodecane (0.10 cSt). The solid line is an exponential fit.  
 
 
Figure 2.8 (cont.) 
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Figure 2.8 Effect of viscosity on fragmentation of potassium chloride. A slurry containing 0.2 
wt% potassium chloride in a dodecane–silicon oil mixture was sonicated using a titanium horn 
(10 W/cm2 and 20 kHz). The solid line is an exponential fit. 
 
2.3.5 Mechanism of sonofragmentation of ionic crystals 
There are four possible contributors to sonofragmentation of materials: interparticle 
collisions, particle–wall collisions, particle–horn collisions, and particle–shockwave/microjet 
interactions.26 Previous papers on sonocrystallization have often assumed that interparticle 
collisions play a major role in fragmentation of growing crystals.32, 54-56 While interparticle 
collisions are important for long ultrasonic irradiation of slurries of metal powders, we found 
recently that this is not the case for molecular solids.26 To understand the breakage of brittle 
materials, we isolated each of these possible contributions to the sonofragmentation of ionic 
crystals and examined them separately (Figure 2.9).  
 
Figure 2.9 (cont.) 
Ti Horn
(a) Piezoelectric stack
Ti Horn
(b) Piezoelectric stack
Ti Horn
(c) Piezoelectric stack
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Figure 2.9 Experimental setups of (a) the normal apparatus showing the immersion of the 
titanium ultrasonic horn into the slurry, (b) decoupling experiments to eliminate particle–wall 
interactions, and (c) decoupling experiments to eliminate particle–horn interactions. 
 
2.3.5.1 Interparticle collisions 
First, we examined the effect of crystal loading on sonicated slurries. Various amounts of 
potassium chloride were loaded as a slurry into dodecane (10 mL).  Regardless of the loading 
of the slurry, the rate of crystal fragmentation was not significantly affected: 140 sec of 
sonication (10 W/cm2, 20 kHz) reduced the initial crystal size to 0.50(3) for slurries ranging 
from 0.07 to 10 wt% (Figure 2.10).  Thus, interparticle collisions do not contribute 
significantly to the sonofragmentation of these crystals. 
 
Figure 2.10 Slurry loading has no significant effect on rates of fragmentation of pota
ssium chloride crystals during sonication. A potassium chloride slurry (loadings from 
0.07 to 10 wt%) in 10mL dodecane was sonicated for 140 seconds using a titanium 
horn (10 W/cm2 and 20 kHz).  
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2.3.5.2 Particle–wall collisions 
Second, particle–wall decoupling experiments were performed at various ultrasonic 
intensities. A latex membrane was placed around the potassium chloride slurry to prevent 
particles from hitting the glass reactor wall (Figure 2.9b). Although particle–wall collisions 
did not occur for particles isolated from the wall, these particles showed slightly greater 
fragmentation than the particles exposed to the wall (Figure 2.11). The slight increase probably 
represents the effective increase in ultrasonic intensity that the confined slurry would have 
experienced within the membrane. These results demonstrate that particle–wall collisions 
were not a major mechanism of ionic crystal fragmentation. 
 
Figure 2.11 Comparison of fragmentation of potassium chloride crystals that were able to 
collide with the reactor wall directly (black line) versus crystals prevented from direct 
collisions with the reactor wall (blue line); cf. Figure 2.9a vs. 2.9b. A potassium chloride slurry 
(0.2 wt%) in 10 mL dodecane was sonicated for 140 seconds using a titanium horn (20 kHz). 
The solid line is an exponential fit.  
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2.3.5.3 Particle–horn collisions 
Third, particle–horn decoupling experiments were carried out by isolating the potassium 
chloride slurry from direct contact with the horn using a latex membrane (Figure 2.9c). The 
solid particles were still fragmented at rapid rates (Figure 2.12), even in the absence of direct 
horn-particle contact. As such, these results demonstrate that particles–horn collisions were 
also not a major contributor to crystal fragmentation. 
 
Figure 2.12 Comparison of fragmentation of potassium chloride crystals that were able to 
collide directly with the ultrasonic horn (black line) versus crystals prevented from direct 
collisions with the horn (red line); cf. Figure 2.9a vs. 2.9c. The slightly lower rates of 
fragmentation in the absence of direct horn contact (red line) is due to attenuation of the 
ultrasound by the latex membrane and the longer distances from the ultrasonic source (i.e. the 
horn tip). A potassium chloride slurry (loading 0.2 wt%) in 10 mL dodecane was sonicated for 
140 seconds using a titanium horn (20 kHz). The solid line is an exponential fit.  
 
Thus, as discussed elsewhere in detail for molecular crystals,26 we must conclude that 
particle breakage of ionic solids irradiated with ultrasound is primarily due to interaction of 
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the solid particles with shockwaves and microjets formed during cavitation, not interparticle 
collisions or particle impact on hard surfaces (e.g., wall or horn).  
 
2.3.5.4 Suggested mechanism of sonofragmentation of ionic crystals 
For comparison, the mechanisms of crack formation in crystals under mechanical impact 
from grinding has been previously discussed.57 When a solid particle is subjected to a strong 
impact, tensile stresses are formed radially outward from the initial point of contact. Cracks 
are generated along these radial lines, leading to eventual particle breakage. In addition, cracks 
can also be generated perpendicular to the radial cracking, due to the buckling of the particles.  
As such, we suggest that there are two general classes of mechanisms for 
sonofragmentation of ionic (or molecular) crystals:  shock-induced compression-expansion 
and shock-induced bending or torsion, as shown schematically in Figure 2.13. It is likely that 
the morphology of the initial crystals will determine the relative importance of these two 
mechanisms:  high aspect ratio solids (i.e., rods, needles, or plates) are much more likely to 
break through bending and torsion than low aspect ratio solids (as used in these studies).  
Breakage of crystals ultimately is a nucleated process due to defects in solids, and is not 
inherently related to the solids’ hardness or bulk modulus. One intuitively expects, however, 
that the rate at which defects are generated in solid particles during strain or impact ought to 
correlate with the strength of materials. This is, if one may, the mechanochemical extension 
of the Bell-Evans-Polanyi principle or of Hammond’s Postulate:  activation energies 
correlate with enthalpies.58-59 Indeed, prior reports have established empirically that fracture 
toughness and fracture strength of  glasses (both silica and metallic) are empirically 
proportional to Young’s modulus.60-61 There are also similar results for various minerals, and 
harder minerals required more energy to be broken.62 As we have now observed for ionic 
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crystalline solids (Figures 2.3), the rate of breakage of ionic crystals correlates strongly with 
both Young’s modulus and the Vickers hardness of these solids: i.e., the kinetics of crystal 
breakage correlates with thermodynamic properties.  
 
Figure 2.13 Two classes of mechanisms of shock fragmentation of crystals. (a) Pressure 
profile of a typical shockwave passing through a liquid; compression and expansion from 
shockwaves, in general, are not symmetric.  (b) Particle breakage from defects formed by 
shock-induced compression and expansion of the initial crystal and (c) particle breakage from 
defects created during shock-induced bending or torsion of the initial crystal. 
2.4 Conclusion 
Fragmentation of various alkali halide crystals was induced by ultrasonic irradiation of 
slurries in organic liquids; exponential decreases in particle size were observed with length of 
sonication. Analysis of the fragmentation mechanism showed that direct interaction between 
alkali halide crystals and shockwaves or microjets, and not interparticle collisions or impaction, 
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were the main cause of sonofragmentation. Shockwave fragmentation of crystals may be 
induced by either compression-expansion or by bending-torsional effects on the solid particles. 
There is a strong correlation of the rate of fragmentation with materials’ properties (i.e., 
Vickers hardness and Young’s modulus). 
 
2.5 References 
1. Beyer, M. K.; Clausen-Schaumann, H., Mechanochemistry: The mechanical 
activation of covalent bonds. Chem. Rev. 2005, 105 (8), 2921-2948. 
2. Jones, W.; Eddleston, M. D., Introductory lecture: mechanochemistry, a versatile 
synthesis strategy for new materials. Faraday Discuss. 2014, 170, 9-34. 
3. Caruso, M. M.; Davis, D. A.; Shen, Q.; Odom, S. A.; Sottos, N. R.; White, S. R.; 
Moore, J. S., Mechanically-induced chemical changes in polymeric materials. Chem. Rev. 
2009, 109 (11), 5755-5798. 
4. Friscic, T.; James, S. L.; Boldyreva, E. V.; Bolm, C.; Jones, W.; Mack, J.; Steed, J. 
W.; Suslick, K. S., Highlights from Faraday discussion 170: Challenges and opportunities of 
modern mechanochemistry, Montreal, Canada, 2014. Chem. Commun. 2015, 51 (29), 6248-
6256. 
5. James, S. L.; Adams, C. J.; Bolm, C.; Braga, D.; Collier, P.; Friscic, T.; Grepioni, F.; 
Harris, K. D. M.; Hyett, G.; Jones, W.; Krebs, A.; Mack, J.; Maini, L.; Orpen, A. G.; Parkin, 
I. P.; Shearouse, W. C.; Steed, J. W.; Waddell, D. C., Mechanochemistry: opportunities for 
new and cleaner synthesis. Chem. Soc. Rev. 2012, 41 (1), 413-447. 
6. Ralphs, K.; Hardacre, C.; James, S. L., Application of heterogeneous catalysts 
prepared by mechanochemical synthesis. Chem. Soc. Rev. 2013, 42 (18), 7701-7718. 
7. Lee, B.; Niu, Z.; Wang, J.; Slebodnick, C.; Craig, S. L., Relative mechanical strengths 
60 
 
of weak bonds in sonochemical polymer mechanochemistry. J. Am. Chem. Soc. 2015, 137 (33), 
10826-10832. 
8. Cravotto, G.; Gaudino, E. C.; Cintas, P., On the mechanochemical activation by 
ultrasound. Chem. Soc. Rev. 2013, 42 (18), 7521-7534. 
9. Suslick, K. S., Mechanochemistry and sonochemistry: concluding remarks. Faraday 
Discuss. 2014, 170, 411-422. 
10. Cintas, P.; Cravotto, G.; Barge, A.; Martina, K., Interplay between mechanochemistry 
and sonochemistry. In Polymer Mechanochemistry, Springer International Publishing: 
Switzerland 2015; Vol. 369. 
11. Guo, Z.; Jones, A. G.; Li, N.; Germana, S., High-speed observation of the effects of 
ultrasound on liquid mixing and agglomerated crystal breakage processes. Powder Technol. 
2007, 171 (3), 146-153. 
12. Wagterveld, R. M.; Boels, L.; Mayer, M. J.; Witkamp, G. J., Visualization of acoustic 
cavitation effects on suspended calcite crystals. Ultrason. Sonochem. 2011, 18 (1), 216-225. 
13. Leighton, T., The acoustic bubble. Academic press: Cambridge: 2012. 
14. Suslick, K. S., Sonochemistry. Science 1990, 247 (4949), 1439-1445. 
15. Suslick, K. S.; Flannigan, D. J., Inside a collapsing bubble: sonoluminescence and the 
conditions during cavitation. Annu. Rev. Phys. Chem. 2008, 59, 659-683. 
16. Pecha, R.; Gompf, B., Microimplosions: cavitation collapse and shock wave emission 
on a nanosecond time scale. Phys. Rev. Lett. 2000, 84 (6), 1328-1330. 
17. Blake, J. R.; Keen, G. S.; Tong, R. P.; Wilson, M., Acoustic cavitation: the fluid 
dynamics of non-spherical bubbles. Philos. Trans. A Math Phys. Eng. Sci. 1999, 357 (1751), 
251-267. 
18. Lauterborn, W.; Vogel, A., Morden optical techniques in fluid mechanics. Annu. Rev. 
61 
 
Fluid Mech. 1984, 16, 223-244. 
19. Shchukin, D. G.; Skorb, E.; Belova, V.; Mohwald, H., Ultrasonic cavitation at solid 
surfaces. Adv. Mater. 2011, 23 (17), 1922-1934. 
20. Prozorov, T.; Prozorov, R.; Suslick, K. S., High velocity interparticle collisions driven 
by ultrasound. J. Am. Chem. Soc. 2004, 126 (43), 13890-13891. 
21. Suslick, K. S.; Doktycz, S. J., The sonochemistry of zinc powder. J. Am. Chem. Soc. 
1989, 111 (6), 2342-2344. 
22. Suslick, K. S.; Casadonte, D. J.; Doktycz, S. J., The effects of ultrasound on nickel 
and copper powders. Solid State Ionics 1989, 32-3, 444-452. 
23. Suslick, K. S.; Casadonte, D. J.; Doktycz, S. J., Ultrasonic irradiation of copper 
powder. Chem. Mater. 1989, 1 (1), 6-8. 
24. Radziuk, D.; Grigoriev, D.; Zhang, W.; Su, D.; Moehwald, H.; Shchukin, D., 
Ultrasound-assisted fusion of preformed gold nanoparticles. J. Phys. Chem. C 2010, 114 (4), 
1835-1843. 
25. Doktycz, S. J.; Suslick, K. S., Interparticle collisions driven by ultrasound. Science 
1990, 247 (4946), 1067-1069. 
26. Zeiger, B. W.; Suslick, K. S., Sonofragmentation of molecular crystals. J. Am. Chem. 
Soc. 2011, 133 (37), 14530-14533. 
27. Deora, N. S.; Misra, N. N.; Deswal, A.; Mishra, H. N.; Cullen, P. J.; Tiwari, B. K., 
Ultrasound for improved crystallisation in food processing. Food Engineering Reviews 2013, 
5 (1), 36-44. 
28. Sander, J. R. G.; Zeiger, B. W.; Suslick, K. S., Sonocrystallization and 
sonofragmentation. Ultrason. Sonochem. 2014, 21 (6), 1908-1915. 
29. Zhang, Z.; Sun, D.-W.; Zhu, Z.; Cheng, L., Enhancement of crystallization processes 
62 
 
by power ultrasound: current state-of-the-art and research advances. Comprehensive Reviews 
in Food Science and Food Safety 2015, 14 (4), 303-316. 
30. Gopi, K. R.; Nagarajan, R., Advances in nanoalumina ceramic particle fabrication 
using sonofragmentation. IEEE Trans. Nanotechnol. 2008, 7 (5), 532-537. 
31. Zhang, L.; Belova, V.; Wang, H.; Dong, W.; Moehwald, H., Controlled cavitation at 
nano/microparticle surfaces. Chem. Mater. 2014, 26 (7), 2244-2248. 
32. Raman, V.; Abbas, A., Experimental investigations on ultrasound mediated particle 
breakage. Ultrason. Sonochem. 2008, 15 (1), 55-64. 
33. Ambedkar, B.; Nagarajan, R.; Jayanti, S., Investigation of high-frequency, high-
intensity ultrasonics for size reduction and washing of coal in aqueous medium. Ind. Eng. 
Chem. Res. 2011, 50 (23), 13210-13219. 
34. Franco, F.; Perez-Maqueda, L. A.; Perez-Rodriguez, J. L., The effect of ultrasound on 
the particle size and structural disorder of a well-ordered kaolinite. J. Colloid Interface Sci. 
2004, 274 (1), 107-117. 
35. Price, G. J.; White, A. J.; Clifton, A. A., The effect of high-intensity ultrasound on 
solid polymers. Polymer 1995, 36 (26), 4919-4925. 
36. Meier, M.; John, E.; Wieckhusen, D.; Wirth, W.; Peukert, W., Influence of mechanical 
properties on impact fracture: Prediction of the milling behaviour of pharmaceutical powders 
by nanoindentation. Powder Technol. 2009, 188 (3), 301-313. 
37. Vogel, L.; Peukert, W., Breakage behaviour of different materials - construction of 
mastercurve for the breakage probability. Powder Technol. 2003, 129 (1-3), 101-110. 
38. Taylor, L. J.; Papadopoulos, D. G.; Dunn, P. J.; Bentham, A. C.; Dawson, N. J.; 
Mitchell, J. C.; Snowden, M. J., Predictive milling of pharmaceutical materials using 
nanoindentation of single crystals. Organic Process Research & Development 2004, 8 (4), 
63 
 
674-679. 
39. Gilman, J. J., Chemistry and physics of mechanical hardness. John Wiley & Sons: 
New York City: 2009; Vol. 5. 
40. Chin, G. Y.; Van Uitert, L. G.; Green, M. L.; Zydzik, G., Hardness, yield strength and 
young's modulus in Halide crystals. Scr. Mater. 1972, 6 (6), 475-479. 
41. Rao, T. T.; Sirdeshmukh, D. B., Microhardness of rubidium halide crystals. Cryst. 
Res. Technol. 1991, 26 (3), K53-K59. 
42. Sirdeshmukh, D. B.; Subhadra, K. G.; Rag, K. K.; Rao, T. T., Hardness of crystals 
with NaCl structure and the significance of the Gilman-Chin parameter. Cryst. Res. Technol. 
1995, 30 (6), 861-866. 
43. Sirdeshmukh, D. B.; Krishna, P. G.; Subhadra, K. G., Micro-macro property 
correlations in alkali halide crystals. J. Mater. Sci. 2003, 38 (9), 2001-2006. 
44. Sirdeshmukh, D. B.; Sirdeshmukh, L.; Subhadra, K. G., Alkali halides: a handbook 
of physical properties. Springer Science & Business Media: Berlin: 2013; Vol. 49. 
45. Neppiras, E. A., Acoustic cavitation. Physics Reports-Review Section of Physics 
Letters 1980, 61 (3), 159-251. 
46. de Vegt, O.; Vromans, H.; Pries, W.; Maarschalk, K. V., The effect of crystal 
imperfections on particle fracture behaviour. Int. J. Pharm. 2006, 317 (1), 47-53. 
47. de Vegt, O.; Vromans, H.; den Toonder, J.; Maarschalk, K. V., Influence of flaws and 
crystal properties on particle fracture in a jet mill. Powder Technol. 2009, 191 (1-2), 72-77. 
48. Didenko, Y. T.; Suslick, K. S., The energy efficiency of formation of photons, radicals 
and ions during single-bubble cavitation. Nature 2002, 418 (6896), 394-397. 
49. Suslick, K. S.; Gawienowski, J. J.; Schubert, P. F.; Wang, H. H., Alkane 
sonochemistry. J. Phys. Chem. 1983, 87 (13), 2299-2301. 
64 
 
50. Suslick, K. S.; Hammerton, D. A.; Cline, R. E., The sonochemical hot-spot. J. Am. 
Chem. Soc. 1986, 108 (18), 5641-5642. 
51. Flint, E. B.; Suslick, K. S., The temperature of cavitation. Science 1991, 253 (5026), 
1397-1399. 
52. Suslick, K. S.; Price, G. J., Applications of ultrasound to materials chemistry. Annu. 
Rev. Mater. Sci. 1999, 29, 295-326. 
53. Majumdar, S.; Kumar, P. S.; Pandit, A. B., Effect of liquid-phase properties on 
ultrasound intensity and cavitational activity. Ultrason. Sonochem. 1998, 5 (3), 113-118. 
54. Kass, M., Ultrasonically induced fragmentation and strain in alumina particles. Mater. 
Lett. 2000, 42, 246-250. 
55. Chu, S.-H.; Choi, S. H.; Kim, J.-W.; King, G. C.; Elliott, J. R., Ultrasonication of 
bismuth telluride nanocrystals fabricated by solvothermal method - art. no. 61720A. In Smart 
Structures and Materials 2006: Smart Electronics, Mems, Biomems, and Nanotechnology, 
Varadan, V. K., Ed. 2006; Vol. 6172, pp A1720-A1720. 
56. Price, G. J.; Mahon, M. F.; Shannon, J.; Cooper, C., Composition of calcium 
carbonate polymorphs precipitated using ultrasound. Crystal Growth & Design 2011, 11 (1), 
39-44. 
57. Potapov, A. V.; Campbell, C. S., The two mechanisms of particle impact breakage 
and the velocity effect. Powder Technol. 1997, 93 (1), 13-21. 
58. Anslyn, E. V.; Dougherty, D. A., Modern physical organic chemistry. University 
Science: Sausalito, CA, 2006. 
59. Dill, K. A.; Bromberg, S., Molecular driving forces. 2 ed.; Garland Science: New 
York, 2011. 
60. Soga, N., Elastic moduli and fracture toughness of glass. J. Non-Cryst. Solids 1985, 
65 
 
73 (1-3), 305-313. 
61. Yuan, C. C.; Xi, X. K., On the correlation of Young's modulus and the fracture 
strength of metallic glasses. J. Appl. Phys. 2011, 109 (3). 
62. Gent, M.; Menendez, M.; Torano, J.; Torno, S., A correlation between Vickers 
hardness indentation values and the bond work Index for the grinding of brittle minerals. 
Powder Technol. 2012, 224, 217-222. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
66 
 
Chapter 3  
Sonofragmentation of molecular crystals 
 
3.1 Introduction 
When ultrasound is applied to a slurry of molecular crystals, shockwaves generated by 
acoustic cavitation interact directly with the molecular crystals to cause fragmentation, i.e., 
sonofragmentation.1 Molecular crystals are composed of molecules held together by weak 
intermolecular forces consisting of dipole-dipole interactions, created by partially charged ions, 
and Van der Waals forces.2 Additionally, the local length scales of these intermolecular forces 
are relatively short.3-4 Thus, molecular crystals tend to be brittle and cannot usually sustain 
their original form and size under ultrasonic irradiation.  
Sonofragmentation can occur during sonocrystallization. This can reduce crystal size in two 
ways: by direct fragmentation of crystals;5-9 and by creating additional, secondary nucleation 
sites for new crystals.10-14 One of the most important applications of sonocrystallization is in 
generating pharmaceutical drugs, many of which are molecular crystals.15-20 Thus, it is 
important to understand the sonofragmentation of molecular crystals in order to predict and 
improve the properties of the final product of sonocrystallization with regard to factors 
including crystal size, size distribution, and crystal morphology.  
It has been reported the effects of various control variables (e.g., acoustic power density, 
frequency, solvent, etc.) on sonofragmentation of molecular crystals.1, 21-24 Also, several 
articles have detailed the mechanical properties of molecular crystals following milling or 
particle impaction.25-28 However, no studies have revealed a direct relationship between a 
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material’s properties and the sonofragmentation of molecular crystals. 
This chapter describes the sonication of slurries of six molecular crystals and four polycyclic 
aromatic hydrocarbon (PAH) crystals. An ultrasonic horn (20 kHz, 10 W/cm2) was used to 
examine their sonofragmentation patterns. Each of the selected crystals was distinct in its 
Vickers hardness (Hv) and Young’s modulus (E),29-31 two of the most critical materials’ 
properties related to fragmentation. In addition, the relationships between Vickers hardness or 
Young’s modulus and the sonofragmentation patterns of molecular, PAH and ionic crystals 
were compared. The effects of initial crystal on sonofragmentation patterns were also 
evaluated. 
 
3.2 Experimental  
3.2.1 Materials  
Lactose, acetaminophen, hexamethylenetetramine, chrysene, 9,10-diphenylanthracene, 
pyrene, anthracene and dodecane were purchased from Sigma-Aldrich. Sucrose was purchase 
from Fisher Scientific. All chemicals were used as-received, unless otherwise indicated. 
Sulfadimethoxine and phenacetin (Sigma-Aldrich) were recrystallized in nanopure water (i.e., 
water deionized to >18 MΩ·cm resistance, scrubbed for organics, and passed through a 0.45 
μm filter with a Barnstead NANOpure® ultrapure water purification system).  
 
3.2.2 Sonofragmentation experimental setup  
10 ml of dodecane was added to 15 mg of molecular crystals. The slurry was allowed to 
thermally equilibrate at 18 °C for 5 minutes in a temperature-controlled water bath (Isotemp 
1006S). This mixture was sonicated with an exponential ultrasonic horn (Sonics and Materials 
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VCX-750, 20 kHz, 1 cm2 Titanium tip, 10 W/cm2) for different times. At 20 kHz, the 
maximum diameter of a cavitating bubble before collapse is ~ 150 μm.32 All sonication 
experiments were performed using a duty cycle of 2 sec on and 8 sec off pulse cycle to reduce 
temperature variation. For all cases, steady state temperatures during sonication were 25 °C. 
Sonication times are reported as the total time exposed to ultrasound. For the 
sonofragmentation experiments of polycyclic aromatic hydrocarbon (PAH) crystals, 10 ml of 
DI water was added to 15 mg of PAH crystals. Other experimental conditions and processes 
were same as those of sonofragmentation experiments of molecular crystals. 
 
3.2.3 Sample preparation of seven groups of sucrose having different crystal size  
In order to check the effect of initial crystal size, a sonic sifter (Advantech Manufacturing, 
Berlin, WI) was used with various sieves (mesh opening sizes 45, 75, 106, 250, 500 and 1000 
μm) to separate batches of sucrose based on their size. The sonic sifter was used for 5 minutes. 
Crystals that were not sieved by the sifter were removed from the sieve. The sieved crystals 
were collected and sieved again with same intensity and time. This process was done total 4 
times for each group of sucrose. For the crystals passing the sieve with 45 μm of mesh opening 
size, vacuum filtration was performed with filter paper (pore size 1.2 μm) and the unfiltrated 
crystals were taken. For the group of the smallest size of sucrose (Group 7), sucrose was 
grounded by mortar and pestle and then sieved with the sieve which mesh opening size was 
45 μm. Crystals smaller than 45 μm collected and dispersed into dodecane. The sucrose‒
dodecane slurry was sonicated with a horn (20kHz and 40 W/cm2) for an hour. After the 
sonication, sucrose was collected again by centrifuge and dried in a vacuum oven at room 
temperature for overnight.  
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3.2.4 Characterization 
An aliquot of sonicated slurry was removed using a disposable pipette for analysis by 
optical microscopy (Zeiss Axioskop optical/fluorescence microscope). The micrographs were 
captures using a Cannon PC1015 digital camera mounted to the microscope. Scanning electron 
microscopy was performed with a JEOL 7000F Analytical SEM. Crystal size analysis with 
optical microscopic or SEM images was performed using Image-J software (National 
Institutes of Health, Bethesda, MD, USA). Approximately 200 particles were measured for 
each experiment. Data fitting was performed using OriginPro 8.5 software (OriginLab, 
Northampton, MA, USA). Vickers hardness and Young’s modulus of PAH crystals were 
measured by Leitz Wetzlar GMBH and Agilent G200 Nanoindenter, respectively. 
 
3.3 Results and discussion 
3.3.1 Sonofragmentation of molecular crystals 
Molecular crystals were fragmented under ultrasonic irradiation (Figure 3.1). The rate of 
fragmentation for the molecular crystals is shown in Figure 3.2. The data revealed an 
exponential reduction in particle size as a function of sonication time. Molecular crystals with 
a higher Vickers hardness and Young’s modulus required longer sonication times to reach half 
their initial crystal size (Table 3.1). 
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Table 3.1 Vickers hardness (Hv), Young’s modulus (E), sonication time necessary to halve the 
initial crystal size (τ1/2) of molecular crystals and initial crystal size. 
Molecular 
crystals 
Hv (GPa) E (GPa) τ1/2 (sec) Initial crystal size 
(μm) 
Sucrose 0.636 32.3 480 678 
Lactose 0.535 24.1 440 664 
Acetaminophen 0.358 18.1 380 561 
Sulfadimethoxine 0.240 N/A 340 442 
Phenacetin 0.172 N/A 310 1162 
Hexamethylene- 
tetramine 
0.133 9.0 260 507 
 
   
Figure 3.1 (cont.) 
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Figure 3.1 Optical micrographs of molecular crystals before and after sonication. (a) Sucrose 
before sonication and (b) after sonication 480 seconds, (c) lactose before sonication and (d) 
after sonication for 440 seconds, (e) acetaminophen before sonication and (f) after sonication 
380 seconds, (g) sulfadimethoxine before sonication and (h) after sonication for 340 seconds, 
(i) phenacetin before sonication and (j) after sonication for 310 seconds, (k) 
hexamethylenetetramine before sonication and (l) after sonication for 210 seconds. Each slurry 
contained 0.2 wt% of molecular crystals in dodecane and was sonicated by using a titanium 
horn (10 W/cm2 and 20 kHz). 
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Figure 3.2 Fraction of initial crystal size versus sonication time for various molecular crystals. 
Slurries containing 0.2 wt% of the molecular crystals in dodecane were sonicated using a 
titanium horn (10 W/cm2 and 20 kHz). Solid lines are exponential fits to the data. Standard 
deviation of each data point is less than 4 % of its average value. 
 
When the sonication time was divided by the Vickers hardness0.35 or Young’s modulus0.5, 
the fractions of initial crystal size were distributed near a master line (Figures 3.3b and d). 
Figures 3.3(a) and (c) show a quantitative relationship between hardness or elasticity and the 
rate of fragmentation. However, the reason for these results has not yet been determined. Other 
critical factors, such as the defect concentration of the starting materials, may play a role in 
fragmentation efficiency. 
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Figure 3.3 Relationship between rate of sonofragmentation and either Vickers hardness or 
Young’s modulus. (a) log Vickers hardness (Hv) vs. log time necessary to halve the initial 
crystal size (τ1/2); and (b) log Young’s modulus (E) vs. log time necessary to halve the initial 
crystal size (τ1/2). Linear fitting was applied. Standard deviation of each data point is less than 
4 % of its average value. 
 
3.3.2 Sonofragmentation of polycyclic aromatic hydrocarbon (PAH) 
The relationship between the Vickers hardness or Young’s modulus and sonofragmentation 
patterns was also examined in four polycyclic aromatic hydrocarbons (PAHs): anthracene, 
pyrene, chrysene, and 9,10-diphenylanthracene (Figure 3.4). PAHs are nonpolar molecular 
crystals that do not have hydrogen bonds. They are held together only by weak intermolecular 
forces such as Van der Waals forces and dipole-dipole interactions between partially charged 
ions.2 These interactions are held only over very short distances.3-4  
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Figure 3.4 Molecular structure of four different PAH: (a) anthracene, (b) pyrene, (c) chrysene 
and (d) 9,10-diphenylanthracene. 
 
The Vickers hardness and Young’s modulus of PAH crystals were measured using a Vickers 
indenter and a nanoindenter, respectively (Table 3.2). The ranges of Vickers hardness and 
Young’s modulus of PAH crystals partially overlapped with those of the molecular crystals 
described in Section 3.3.1. PAH crystals were broken during sonication of the slurries (Figure 
3.5). The time required for the crystals to reach half their initial size (τ1/2) increased with the 
Vickers hardness or Young’s modulus of the parent material. Figure 3.6 shows that there is a 
quantitative relationship between the rate of fragmentation and the hardness or elasticity of 
PAH crystals. 
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Table 3.2 Vickers hardness (Hv), Young’s modulus (E), sonication time necessary to halve the 
initial crystal size (τ1/2) of PAH crystals and initial crystal size.* 
PAH crystals Hv (GPa) E (GPa) τ1/2 (sec) Initial crystal size (μm) 
9,10-
diphenylanthracene  
0.213  
(0.025) 
12.79 
(2.43) 
300 793 
Chrysene 0.182  
(0.014) 
13.64 
(1.73) 
310 677 
Pyrene  0.071  
(0.012) 
7.57 
(0.57) 
270 748 
Anthracene 0.052  
(0.011) 
9.35 
(1.6) 
270 925 
*Hv and E were measured three times and five times, respectively, and the values of Hv and E 
are average values. 
 
  
Figure 3.5 (cont.) 
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Figure 3.5 Optical micrographs of PAH crystals before and after sonication. (a) 9,10-
diphenylanthracene before sonication and (b) after sonication for 300 seconds, (c) chrysene 
before sonication and (d) after sonication for 310 seconds, (e) pyrene before sonication and (f) 
after sonication 270 seconds, (g) anthracene before sonication and (h) after sonication for 270 
seconds. Each slurry contained 0.2 wt% of PAH crystals in DI water and was sonicated by 
using a titanium horn (10 W/cm2 and 20 kHz). 
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Figure 3.6 Relationship between (a) Vickers hardness (Hv) and the time necessary to halve the 
initial crystal size (τ1/2) and (b) Young’s modulus (E) and the time necessary to halve the initial 
crystal size (τ1/2). The dashed lines are linear fits. Standard deviation of each data point is less 
than 4 % of its average value. 
 
3.3.3 Comparison of sonofragmentation patterns between ionic, molecular and PAH 
crystals 
Sonofragmentation occurred following sonication of slurries containing ionic, molecular, or 
PAH crystals. A quantitative relationship between hardness or elasticity and the rate of 
fragmentation was observed in each case (Section 2.3.1, 3.3.1 and 3.3.2). In Figure 3.7(a), the 
slope of the fitted lines of ionic crystals is the steepest among the lines representing ionic, 
molecular, and PAH crystals. This indicates that, among the three types of crystals, 
sonofragmentation of ionic crystals was the most sensitive to the change of hardness of the 
parent materials. However, the three types of crystals showed similar sensitivity of 
sonofragmentation to the change of Young’s modulus (Figure 3.7b).  
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Figure 3.7 Comparison of the relationships between (a) Vickers hardness (Hv) and the time 
necessary to halve the initial crystal size (τ1/2) of ionic, molecular and PAH crystals and (b) 
Young’s modulus (E) and the time necessary to halve the initial crystal size (τ1/2) of ionic, 
molecular and PAH crystals. The dashed lines are linear fits. Standard deviation of each data 
point is less than 4 % of its average value. 
 
Ionic, molecular, and PAH crystals are held together by different types of intermolecular 
interactions. In ionic crystals, the major and minor intermolecular forces are ion-to-ion 
attraction and Van der Waals forces, respectively.33 In contrast, molecular crystals and PAH 
crystals are held together by dipole-dipole interactions, created by partially charged ions, and 
Van der Waals forces. Additionally, the molecular crystals used herein are capable of forming 
intermolecular hydrogen bonds (Figure 3.8), which are not possible in PAH crystals. Ion-ion 
interactions are the strongest of the intermolecular forces, followed by hydrogen bonding, 
dipole-dipole interactions, and Van der Waals forces, respectively. Thus, the order of 
intermolecular bond strength with regard to the materials evaluated here is ionic crystals > 
molecular crystals > PAH crystals.  
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Figure 3.8 Molecular structure of six different molecular crystals: (a) sucrose, (b) lactose, (c) 
acetaminophen, (d) sulfadimethonxine, (e) phenacetin and (f) hexamethylenetetramine. 
 
The length scale of order depends on the type of crystal due to the difference of the 
intermolecular bond strengths. Ionic crystals are held in long-range order while molecular and 
PAH crystals feature only short-range intermolecular interactions.3-4 Particle breakage initiates 
from pre-existing defects in the particle, which propagate until cleavage is attained. The length 
scale of order may affect the propagation of cracks and thereby affect the sensitivity of 
sonofragmentation to a material’s hardness. There are more parameters to affect particle 
breakage such as number and size of the initial defects.34-35 Thus, the combined effect of the 
other parameters and the length scale of order may cause the different sensitivity of 
sonofragmentation to a material’s hardness for ionic, molecular and PAH crystals. 
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3.3.4 Effect of initial crystal size 
The effects of initial crystal size on sonofragmentation were also evaluated. Sucrose was 
prepared with seven different particle sizes by sieving in a sonic sifter (Figure 3.9). Grinding, 
sieving, and sonication were used to prepare the particles in Group 7. Figures 3.10 and 3.11 
show the morphologies and crystal sizes of particles in each sucrose group. Initial crystal sizes 
ranged from 1054 µm down to 0.56 µm (Figure 3.12). 
 
Figure 3.9 Preparation method of various sucrose groups containing different crystal size.  
 
81 
 
 
Figure 3.10 Optical microscopic images of sucrose in (a) group 1, (b) group 2, (c) group 3, (d) 
group 4, (e) group 5 and (f) group 6.  
 
 
Figure 3.11 SEM images of sucrose in group 7. 
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Figure 3.12 Crystal size distributions of sucrose in (a) group 1, (b) group 2, (c) group 3, (d) 
group 4, (e) group 5, (f) group 6 and (g) group 7.  
 
No effects of initial crystal size were observed on the rates of fragmentation of molecular 
crystals when the initial crystal size was from 1054 to 68 μm (Figure 3.13). However, 
sonofragmentation was suppressed when the initial crystal was smaller than about 15 μm. No 
sonofragmentation was observed with crystals measuring about 0.56 μm. When the molecular 
crystal slurries were irradiated by ultrasound, the crystals were broken by direct interaction 
with shockwaves. Under continuous sonication, crystals kept breaking until they were too 
small to be fragmented by shockwaves passing through the slurry. When the crystals reach 
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smaller size than the minimum size for sonofragmentation, negative pressure of the irradiated 
ultrasound cannot exceed tensile strength over the length of the crystal. The minimum size for 
sonofragmentation may depend on the frequency and intensity of the irradiated ultrasound. In 
these experiments, performed using an ultrasound source operating at 20 kHz and 10 W/cm2, 
molecular crystals smaller than about 0.56 μm did not experience any further breakdown. 
 
Figure 3.13 Effect of initial crystal size on fragmentation of sucrose. A slurry containing 0.2 
wt% sucrose in 10 mL dodecane was sonicated using a titanium horn (10 W/cm2 and 20 kHz). 
Standard deviation of each data point is less than 7 % of its average value. 
 
3.4 Conclusion 
Molecular crystals were sonofragmented by ultrasonic irradiation to the slurries of 
molecular crystals. The particle size of the molecular crystals decreased exponentially as the 
duration of sonication increased. There was a strong correlation between the rate of 
fragmentation and the Vickers hardness or Young’s modulus of the parent material. Based on 
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comparisons of the sonofragmentation patterns obtained from ionic and molecular crystals, it 
was hypothesized that the length scale of intermolecular forces within a crystal affects 
sonofragmentation patterns.  
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Chapter 4  
Spray sonocrystallization 
 
4.1 Introduction 
Controlling crystal size and size distribution are crucial in the pharmaceutical industry due 
to the effects of size on dissolution rates and bioavailability.1-5 For orally-ingested drugs, 
pharmaceutical agents (PAs), once dissolved, must have sufficient lipophilicity to move across 
cell membranes but sufficient hydrophilicity to be transported within the body.6-8 For 
moderately hydrophobic PAs, however, rates of dissolution after ingestion can be problematic 
unless the PA crystal size is sufficiently small.9-10 Aerosol drugs also require control of the 
particle size and size distribution to successfully administer dosage: particles too large will not 
get into the deep lung, particles too small will be less easily trapped but more easily absorbed.11 
Parenteral (injected) drugs must also control particle size because potentially fatal embolisms 
can result with particles larger than ~5 μm.12 
The application of ultrasound during crystallization (i.e., “sonocrystallization”) has 
emerged as an effective means to reduce crystal size and maintain a narrow size distribution. 
When ultrasound is applied to a liquid, acoustic cavitation occurs: bubbles are formed in the 
liquid, oscillate and expand, and under certain conditions, implosively collapse.13-15 Bubble 
collapse generates intense local heating (~5000 K), pressures (~105 kPa) and rapid heating and 
cooling rates (> 1010 K/s).15-18 Acoustic cavitation and associated physical consequences of 
ultrasonic irradiation of liquids increase the number of crystals produced and decreases their 
size by increasing the rates of both primary and secondary nucleation of crystal growth.  
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The rates of primary nucleation of embryonic crystallites are increased by ultrasonic 
irradiation of liquids through three mechanisms: (1) Improved micro-scale mixing occurs from 
cavitation and associated turbulence, which accelerates diffusion rates of reactants, thus 
reducing induction times for crystallization.19-22 Reduced induction time will increase the rate 
of nucleation by increasing the growth rates of embryonic crystallites, which prevents their 
redissolution.23 (2) Through similar phenomena, ultrasound also reduces the metastable zone 
width (MZW, i.e., the range of metastability of a supersaturated solution in either temperature 
or antisolvent concentration23), which diminishes the rate of crystal growth and decreases 
crystal size.21, 24-26 (3) The increase in gas-liquid interfaces produced by bubble formation, 
collapse, and fragmentation can also enhance nucleation rates.23  
Rates of secondary nucleation are also increased by ultrasonic irradiation. Breakage of 
primary crystals due to interparticle collisions or more importantly shockwave fragmentation 
during sonication (i.e., “sonofragmentation”)27-28 increases the number of secondary 
nucleation sites, which results in increased numbers of smaller crystals. Turbulent flow from 
cavitation will also diminish crystal aggregation, which also produces smaller solid 
particulates with narrower size distribution. 
Antisolvent crystallization (i.e., adding a miscible liquid in which the solute is poorly 
soluble) can generate a high level of supersaturation quickly and induce higher nucleation 
rates.4, 23, 29-32 In principle, ultrasound should be beneficial for antisolvent crystallization 
through enhanced mixing between the antisolvent and solution; in practice, however, the 
ultrasound from a solid horn has been applied to the merging of fairly wide streams (25 mm) 
of solvent and antisolvent or to a large volume batch reactor of antisolvent into which the 
solute solution is pumped; this configurations lead to ineffective application of the ultrasound 
with relatively poor mixing, which typically generates multi-micron sized crystals.33-38   
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In this chapter, a spray sonocrystallization method is described here for the crystallization 
of pharmaceutical agents that provides for a tunable crystal size and narrow size distribution 
in the sub-micron regime. spray sonocrystallization uses a tapped, flow-through ultrasonic 
horn (20 kHz) to spray very fine droplets of the solute containing solution into a continuous 
flow of antisolvent which induces immediate crystallization with extremely effective mixing.  
The analgesic 2-carboxyphenyl salicylate (CPS) was explored as a test case. 
 
4.2 Experimental  
4.2.1 Materials 
2-carboxyphenyl salicylate (CPS), polyvinylpyrrolidone (average mol wt 10,000) and 
sodium dodecyl sulfate (> 95 %) were purchased from Tokyo Chemical Industry, Sigma-
Aldrich and Fisher Chemicals, respectively, and used as-received. Ethanol (100 %) was 
purchased from Decon Laboratory. Nanopure water (i.e., water deionized to >18 MΩ·cm 
resistance, scrubbed for organics, and passed through a 0.45 μm filter with a Barnstead 
NANOpure® ultrapure water purification system) was used as an antisolvent.  
 
4.2.2 Spray sonocrystallization experimental setup 
2-carboxyphenyl salicylate (CPS, Tokyo Chemical Industry, > 98.0 %) was dissolved in 
ethanol (Decon Labs, Inc., 100 %) to form a saturated CPS solution. The CPS solution was 
pumped with a syringe pump through a tapped ultrasonic horn (i.e., a hole drilled from top to 
bottom of the horn, cf. Figure 4.1; Sonics and Materials dual inlet atomizing probe VCX 130 
AT, 20 kHz), exiting from the bottom (an acoustic antinode of the horn) into the mixing region 
of the flow cell into which the antisolvent (water) was also pumped. The CPS solution was 
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kept in a water bath (Fisher Scientific Isotemp 1006S) set to 18 °C prior to transferring to 
syringe. The solution was filtered using a syringe filter (Thermo Scientific Nalgene Syringe 
Filter, pore size 0.2 μm) and transferred to the syringe of a syringe pump (Harvard Apparatus 
Compact Infusion Pump), which was set to 0.08 mL/min. The ultrasonic horn was immersed 
in a flowing antisolvent of nanopure water (i.e., water deionized to >18 MΩ·cm resistance, 
scrubbed for organics, and passed through a 0.45 μm filter with a Barnstead NANOpure® 
ultrapure water purification system). The initial temperature of nanopure water was set to 
18 °C using a water bath; its flow as set to 48 mL/min using a peristaltic pump (Cole-Parmer 
Instrument Company MasterFlex 77390-00). The CPS solution was rapidly dispersed into the 
antisolvent via momentum transfer from the ultrasonic horn. The ultrasonic power delivered 
by the tapped horn was calorimetrically determined and set to 15 W/cm2. Aliquots of the 
sonicated mixture were collected every minute and diluted in 10 mL of nanopure water. For 
characterization, product was collected after a full steady state was reached, specifically after 
6 min. The surfactants, polyvinylpyrrolidone (Sigma-Aldrich, average mol wt 10,000) and 
sodium dodecyl sulfate (Fisher Chemical, > 95 %) were dissolved in nanopure water, and those 
PVP and SDS aqueous solutions were used as the antisolvent and dilution solvent during 
product collection. 
 
4.2.3 Sonocrystallization without flow experimental setup 
For sonocrystallization without flow of an antisolvent, CPS solution and a round bottom 
flask containing 288 ml of nanopure water were kept in water bath in order to set to 18 °C. 
The CPS solution was filtered using a syringe filter and transferred to the syringe of a syringe 
pump, which was set to 0.08 mL/min. The ultrasonic horn (20 kHz, 15 W/cm2) was immersed 
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in the round bottom flask and sonication was performed for 6 minutes from the time when the 
CPS solution and nanopure water were mixed. The equilibrium temperature, 25 °C, was 
reached after about 2 minutes. Aliquots of the sonicated mixture were collected and diluted in 
10 mL of nanopure water. The surfactants, polyvinylpyrrolidone and sodium dodecyl sulfate 
were dissolved in nanopure water, and those PVP and SDS aqueous solutions were used as the 
antisolvent and dilution solvent during product collection. 
 
4.2.4 Solubility test 
Solutions of CPS in ethanol, 1-propanol, methanol, acetone, or a 1:600 v/v solution of 
ethanol in nanopure water were prepared at concentrations of 0.05, 0.10, 0.15 and 0.20 mM. 
UV-Vis absorption of each solution was measured by UV-Vis spectrometer (PerkinElmer 
Lambda 35). Molar absorptivity coefficients were calculated at the absorption peak at 308 nm. 
Saturated solutions in each solvent system was prepared by adding CPS in excess with stirring 
for 1 day at room temperature. The supernatants were filtered through a syringe filter (Thermo 
Scientific Nalgene Syringe Filter, pore size 0.2 μm) to remove any particulates of CPS before 
UV-Vis analysis. The initially saturated CPS solutions were diluted and UV-visible absorption 
spectra measured. In the case of pure water, the low solubility of CPS precluded measuring 
the molar absorptivity coefficient. For measurement of CPS solubilities in ethanol as a 
function of temperature, the same method was used with the ethanol solutions saturated at 
specific temperatures of 7, 12, 33, 46, 55. and 65 °C for 1 day. 
 
4.2.5 Characterization 
Particle size and zeta potential were measured at room temperature by Malvern Zetasizer 
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Nano ZS. Average values and standard deviations of results for the DLS (dynamic light 
scattering) measurements from eight measurements. Optical microscopy was performed with 
a Zeiss Axioskop optical/fluorescence microscope. The micrographs were captures using a 
Cannon PC1015 digital camera mounted to the microscope. Scanning electron microscopy 
was performed with a Hitachi S4700 High Resolution SEM and a JEOL 7000F Analytical 
SEM.  Particle size analysis from SEM images was performed using Image-J (NIH). Powder 
X-ray diffraction patterns were obtained from samples mounted on a quartz sample holder 
using a Bruker D-5000 (λ = 1.5418 Å, 25 °C) in the 2θ range 5-50°; domain size was calculated 
with the Jade X-ray analysis program. 
 
4.3 Results and discussion 
4.3.1 Spray sonocrystallization system 
Intense ultrasound with an antisolvent crystallization method in a continuous flow reactor 
equipped with a specially designed flow-through ultrasonic horn (Figure 4.1). The horn has a 
channel drilled down its center and the PA-solvent solution flows through that channel and is 
atomized upon its exit from the horn into a flowing stream of antisolvent. The momentum 
transfer and micromixing created by acoustic cavitation13-15 forms a fine dispersion of the PA-
solvent into the flowing antisolvent, which substantially increases the rate of solvent-
antisolvent mixing and leads to rapid formation of nanocrystals at the 100 nm scale. As shown 
in Figure 4.2, thorough mixing of solvent and antisolvent occurs within 100 ms.  
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Figure 4.1 Tapped flow-through ultrasonic horn and experimental rig for spray 
sonocrystallization. 
 
 
Figure 4.2 Mixing pattern of solution (red, flowing from the tapped ultrasonic horn) and 
antisolvent (white, flowing from the lower right) within the spray sonocrystallization rig. The 
second frame marks the start of sonication. Frames were extracted from video every 33 ms. 
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4.3.2 Solubility test of 2-carboxyphenyl salicylate (CPS) 
The analgesic 2-carboxyphenyl salicylate (CPS) was selected as a model system. The 
solubility of CPS was determined at room temperature in various solvents (Table 4.1); for 
example, CPS has high solubility in ethanol (ca. 349 mg/ml), but is poorly soluble in water 
(<0.01 mg/ml). Based on solubility differences, ethanol and water were chosen as a solvent 
and an antisolvent, respectively. The solvent and antisolvent were mixed ultrasonically with a 
mixing ratio of water to CPS solution of 600:1. Thermal equilibration occurred rapidly (< 1 
min) after energizing the ultrasonic horn (~7 °C rise); unless otherwise specified eaction zone 
temperature was 25 °C. 
 
Table 4.1 Solubility of CPS in selected solvents. 
Solvent Nanopure 
Water 
Ethanol-
Water 
1:600 v/v 
1-Propanol Ethanol Methanol Acetone 
Solubility of 
CPS (mg ml-1) 
< 0.01 0.08 257 349 494 702 
 
4.3.3 Spray sonocrystallization of CPS 
Spray sonocrystallization produced CPS nanocrystals. Particle size measurements were 
made by dynamic light scattering (DLS) measurements after 6 min, by which time a crystal 
size steady state was fully realized (Figure 4.3). The average crystal diameter is 91 ± 5 nm and 
96% of crystals are in the size range between ca. 60 and 190 nm (Figure 4.4). The zeta potential 
of sonocrystallized CPS is -37 ± 6 mV, which is considered in the moderate stability range (± 
30 ~ ± 40 mV).39 
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Figure 4.3 Crystal size of sonocrystallized CPS as a function of flow time. Steady state is 
achieved after ~3 min. Reliable DLS measurements were not available for the sample of 1 
minute due to high polydispersivity. The error bar of data at 2 min. is smaller than the diamond 
symbol. Saturated CPS solutions in ethanol were mixed into water with a flow ratio of 1:600 
at 25°C.  
 
 
Figure 4.4 Crystal size distribution of sonocrystallized CPS from size analysis of SEM images. 
Sonicated CPS sample without a surfactant was collected after 6 min. after energizing the horn. 
Saturated CPS solutions in ethanol were mixed into water with a flow ratio of 1:600 at 25 °C. 
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The sonocrystallized CPS crystals in solution are well dispersed, but after centrifugation or 
evaporation agglomeration occurs; the agglomerates consist of ca. 100 nm crystals, which 
match the average crystal diameter value from solution DLS measurements (Figure 4.5).  
 
Figure 4.5 Microscopic images of sonocrystallized CPS: (Top) optical microscope images of 
sonocrystallized CPS in the collecting solvent (i.e. too small to see optically), (Bottom) SEM 
images of sonocrystallizaed CPS after evaporation.  
 
4.3.4 Control experiments 
4.3.4.1 Antisolvent crystallization of CPS with stirring 
Repeating CPS crystallization in the same cell with the same flow in the absence of 
ultrasound, but with mechanical mixing (900 rpm, magnetic stir bar), failed to yield product 
measurable by DLS due to formation of large crystals and aggregation (> ~100 μm). 
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Mechanically stirred flow crystallization produces ~10 micron sized crystals that are heavily 
aggregated (Figure 4.6). Despite the agglomeration of the sonocrystallized CPS after 
evaporation (Figure 4.5), there is a clear size reduction of the crystals compared to 
crystallizations that employ the same flow but with mechanical stirring instead of ultrasound.  
 
Figure 4.6 Microscopic images of CPS crystallized via 900 rpm mechanical stirring: (Left) 
Optical microscope images of stirred CPS in the collecting solvent, (Right) SEM images of 
stirred CPS after evaporation. 
 
4.3.4.2 Spray sonocrystallization of CPS without antisolvent flow 
CPS crystals were generated by sonocrystallization in the absence of antisolvent flow. The 
size of each crystal was ~5 micron size and crystals were heavily agglomerated. Thus, crystal 
size reduction was only achieved when sonocrystallization was performed in flow system 
(Figure 4.7). 
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Figure 4.7 Microscopic images of sonocrystallizaed CPS without flow of the antisolvent: 
(Left) Optical microscope images of sonocrystallized CPS in the collecting solvent, (Right) 
SEM images of sonocrystallized CPS after evaporation. Saturated CPS solutions in ethanol 
were mixed into water with a ratio of 1:600 at 25 °C. 
 
4.3.5 Addition of surfactant in spray sonocrystallization of CPS 
Sonocrystallized CPS nanoparticels were dispersed well in the collecting solvent, but they 
were heavily aggregated after the evaporation of the solvent. The addition of surfactants was 
examined to improve the redispersion of CPS nanocrystals during their isolation (e.g., by 
centrifugation, or evaporation); specifically, either a nonionic (polyvinylpyrrolidone, PVP) or 
an anionic surfactant (sodium dodecyl sulfate, SDS) were added to the antisolvent before the 
spray sonocrystallization. Crystal size was only mildly affected by the surfactant addition 
(Table 4.2 and Figures 4.8-9). 
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Table 4.2 Average crystal size and zeta potential of sonocrystallized CPS from DLS 
Measurement. 
Surfactant 
Concentration, wt% 
No 
surfactant 
PVP 0.001 PVP 0.01 SDS 0.001 SDS 0.01 
Crystal Size, nm 91 ± 5 106 ± 4 99 ± 7 121 ± 9 127 ± 4 
Zeta Potential, mV -37 ± 6 -13 ± 2 -18 ± 2 -60 ± 4 -76 ± 9 
 
 
Figure 4.8 Crystal size distributions of sonocrystallized CPS-PVP 0.001 wt% from (a) DLS 
measurements and (b) particle size analysis of SEM images; sonocrystallized CPS-PVP 0.01 
wt% from (c) DLS measurement and (d) particle size analysis of SEM images. 
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Figure 4.9 Crystal size distribution of sonocrystallized CPS-SDS 0.001 wt% from (a) DLS 
measurements and (b) particle size analysis of SEM images; sonocrystallized CPS-SDS 0.01 
wt% from (c) DLS measurement and (d) particle size analysis of SEM images. 
 
The surface charge (i.e., zeta potential) of sonocrystallized CPS is affected by the addition 
of surfactants, as expected. Addition of PVP diminishes the surface charge of the CPS-PVP 
nanocrystals since PVP increases the thickness of the diffuse double layer.40 As expected, 
addition of SDS significantly increases the zeta potential of the CPS-SDS crystals, placing 
them in the excellent stability range (> ± 40),39 and reduces the expected likelihood of 
aggregation.  
PVP is often used as a dispersant for colloidal solutions and works as a sterically bulky 
coating of nanoparticles to prevent aggregation. SDS, on the other hand, has a strong negative 
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charge in aqueous solutions and it can prevent aggregation by providing a surface charge upon 
adsorption to nanoparticle surfaces. Indeed, both surfactants work well to preserve the 
dispersion of the sonocrystallized nanoparticles. The sonocrystallized CPS-PVP nanocrystals 
are well-dispersed due to the steric bulk of the PVP substituents, whereas SDS is effective at 
minimizing agglomeration of CPS crystals, due to the anionic nature of SDS and the resulting 
more negative zeta potential of CPS-SDS nanocrystals (Figure 4.10).  
 
Figure 4.10 SEM images of sonocrystallized CPS with the addition of surfactants to the 
antisolvent (i.e., water): (a) 0.001 wt% PVP, (b) 0001 wt% PVP, (c) 0.001 wt% SDS and (d) 
0.01 wt% SDS. 
 
Addition of PVP or SDS to solutions that undergo CPS crystallization via mechanical 
stirring, however, still yielded massively agglomerated product (Figures 4.11-12). In the 
absence of antisolvent flow, sonocrystallized CPS are not dispersed and yield an agglomerated 
product (Figures 4.13-14) even in the presence of PVP or SDS. 
103 
 
 
Figure 4.11 Optical microscopy micrographs of the solid obtained with rapid mechanical 
stirring (900 rpm) only; (a) CPS-PVP 0.001 wt%, (b) CPS-PVP 0.01 wt%, (c) CPS-SDS 0.001 
wt%, (b) CPS-SDS 0.01 wt%.  
 
 
Figure 4.12 (cont.) 
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Figure 4.12 SEM images of mechanically stirred (900 rpm) crystallization of CPS with the 
addition of surfactants to the antisolvent (i.e., water): (a) 0.001 wt% PVP, (b) 0.01 wt% PVP, 
(c) 0.001 wt% SDS and (d) 0.01 wt% SDS. 
 
 
Figure 4.13 Optical microscopy micrographs of the solid obtained from sonocrystallization 
of CPS without flow of the antisolvent; (a) CPS-PVP 0.001 wt%, (b) CPS-PVP 0.01 wt%, (c) 
CPS-SDS 0.001 wt%, (b) CPS-SDS 0.01 wt%.  
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Figure 4.14 Sonocrystallized CPS with the addition of surfactants to the antisolvent (i.e., water) 
and the absence of the antisolvent flowing: (a) 0.001 wt% PVP, (b) 0.01 wt% PVP, (c) 0.001 
wt% SDS, and (d) 0.01 wt% SDS.  
 
4.3.6 Powder X-ray diffraction patterns 
Powder x-ray diffraction established good crystallinity in sonocrystallized CPS, CPS-PVP, 
and CPS-SDS nanocrystals, as well as crystals from mechanical stirring (Figures 4.15-16). 
There was no significant change of crystal domain size for all samples (Table 4.3). 
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Figure 4.15 Powder X-ray diffraction patterns with and without addition of PVP. (a) CPS 
calculated from single crystal X-ray diffraction data, (b) as-purchased CPS, (c) 
sonocrystallized CPS, (d) CPS crystallized via mechanical stirring, (e) sonocrystallized CPS-
PVP 0.001 wt%, (f) CPS-PVP 0.001 wt% crystallized via mechanical stirring, (g) 
sonocrystallized CPS-PVP 0.01 wt% and (h) CPS-PVP 0.01 wt% crystallized via mechanical 
stirring. Single crystal data was reported in the Cambridge Structural Database (refcode 
WOQDAH). Single crystal data was collected at 150 K and powder patterns were collected at 
room temperature. 
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Figure 4.16 Powder X-ray diffraction patterns of (a) CPS calculated from single crystal X-ray 
diffraction data, (b) as-purchased CPS, (c) sonocrystallized CPS, (d) CPS crystallized via 
mechanical stirring, (e) sonocrystallized CPS-SDS 0.001 wt%, (f) CPS-SDS 0.001 wt% 
crystallized via mechanical stirring, (g) sonocrystallized CPS-SDS 0.01 wt% and (h) CPS-
SDS 0.01 wt% crystallized via mechanical stirring. Single crystal data was reported in the 
Cambridge Structural Database (refcode WOQDAH). Single crystal data was collected at 150 
K and powder patterns were collected at room temperature. 
 
Table 4.3 Crystal domain size of CPS samples with and without addition of PVP or SDS, 
determined from the Debye-Scherrer equation. 
Sample Domain Size (nm) 
Purchased CPS 58 
Sonocrystallized CPS 51 
CPS crystallized via mechanical stirring 38 
Sonocrystallized CPS-PVP 0.001 wt% 51 
CPS-PVP 0.001 wt% crystallized via mechanical stirring 49 
Sonocrystallized CPS-PVP 0.01 wt% 47 
CPS-PVP 0.01 wt% crystallized via mechanical stirring 39 
Sonocrystallized CPS-SDS 0.001 wt% 49 
CPS-SDS 0.001 wt% crystallized via mechanical stirring 36 
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Table 4.3 (cont.) 
Sonocrystallized CPS-SDS 0.01 wt% 47 
CPS-SDS 0.01 wt% crystallized via mechanical stirring 35 
 
For pharmaceutical agents, a significant problem can be the conversion of metastable 
crystallites to other morphologies. For this reason, it was examined the powder X-ray 
diffraction (PXRD) of sonocrystallized CPS over a period of several months. CPS crystals, 
which were generated without or with a surfactant, were centrifuged and dried in a vacuum 
oven at room temperature immediately after sonocrystallization. They were then stored at 
room temperature in air as a dried powder and the powder X-ray diffraction was measured 
periodically: no changes in the PXRD were observed over a 10 months period (Figure 4.17). 
 
Figure 4.17 Powder X-ray diffraction patterns of (a) CPS calculated from single crystal X-ray 
diffraction data, (b) as-purchased CPS, (c) sonocrystallized CPS, (d) sonocrystallized CPS 
after 10 months, (e) sonocrystallized CPS-PVP 0.001 wt% after 10 months, (f) 
sonocrystallized CPS-PVP 0.01 wt% after 10 months, (g) sonocrystallized CPS-SDS 0.001 wt% 
after 10 months, (h) sonocrystallized CPS-SDS 0.01 wt% after 10 months Single crystal data  
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Figure 4.17 (cont.) 
was reported in the Cambridge Structural Database (refcode WOQDAH). Single crystal data 
was collected at 150 K and powder patterns were collected at room temperature. 
 
4.3.7 Modifications of control variables 
In our spray sonocrystallization method, there are various parameters that might affect the 
sonocrystallization process, including ultrasonic power, flow rate of both antisolvent and 
solute solution, concentration of pharmaceutical agent, etc. We have found that the spray 
sonocrystallization process is robust to most of these variables: the only parameter that has a 
significant effect on nanocrystal size is the initial solute concentration. Based on DLS 
measurements, there were no significant changes to average crystal size when ultrasonic power 
and flow rate were systematically changed (Table 4.4-5). Similarly, the use of different 
solvents gave rise to only modest changes in the average crystal size.  
 
Table 4.4 Effect of ultrasonic power. With horn turned off, CPS crystals formed micron sized 
aggregations, and DLS measurement was not possible. 
Ultrasonic Power 
(W/cm2) 
Crystal Size (± s.d.), nm 
0 N/A (large agglomerates) 
5 91 (± 14) 
15 91 (± 5) 
25 116 (± 12) 
 
Table 4.5 Effect of flow rate with fixed mixing ratio between antisolvent and CPS solution 
(600 : 1). 
Flow Rate of Antisolvent 
 (ml/min) 
Flow Rate of CPS Solution 
 (ml/min) 
Crystal Size (± s.d.), nm 
48 0.08 91 (± 5) 
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Table 4.5 (Cont.) 
30 0.049 96 (± 7) 
20 0.033 111 (± 11) 
 
In contrast, however, as the concentration of CPS was increased in the acetone solute 
solution, the average crystal size also increased (with water as the antisolvent), as shown in 
Figure 4.18 and Table 4.6. The CPS concentration was also modified via temperature changes 
using saturated solutions initially over the range of 7 to 46 °C. As temperature increases, the 
solubility of CPS increases exponentially (Figure 4.19), and the average crystal size also 
increases (Figure 4.18, Table 4.7). Based on the results of sonocrystallized CPS in acetone and 
ethanol with various concentrations, it can be concluded that the higher concentration of CPS 
produces larger crystals (Figure 4.18), with an accessible nanocrystal size range of 80 to 180 
nm, in this system. 
 
Figure 4.18 Effect of initial CPS concentration on sonocrystallized CPS size. For acetone, all 
experiments were at 25 °C; for ethanol, solutions were saturated and crystallizations run at 
different initial temperatures ranging from 7 to 46 °C.  
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Table 4.6 Effect of initial CPS concentration in acetone at 25 °C. 
Dissolved  amount of CPS,   
mg/ml 
Initial CPS Concentration, 
M 
Crystal Size (± s.d.), 
nm 
100 0.39 No crystals 
200 0.77 No crystals 
300 1.16 91 (± 7) 
400 1.55 104 (± 13) 
500 1.94 119 (± 3) 
600 2.32 136 (± 6) 
700*  
(Saturated solution) 
2.71 N/A 
(aggregation) 
*For this highest concentration (a saturated solution of CPS), aggregated crystals appeared 
immediately upon mixing of water and CPS solution even in the presence of ultrasound, due 
to the large solubility difference between CPS in acetone (702 mg/ml) vs. water (< 0.01 mg/ml).  
 
  
Figure 4.19 Solubility of CPS in ethanol at a function of temperature. 
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Table 4.7 Effect of initial CPS concentration in ethanol at different temperatures. Initial 
solutions of CPS were saturated at each temperature. 
Temperature of Initial 
CPS Solution (°C)* 
Dissolved amount of 
CPS (mg/ml) 
Initial CPS 
Concentration 
(M) 
Crystal Size 
(± s.d.), nm 
7 241 0.93 77 (± 16) 
25 349 1.35 91 (± 5) 
33 561 2.17 124 (± 8) 
46 940 3.64 175 (± 6) 
* Final steady state temperatures in the mixing zone were 12, 25, 40, and 55°C, respectively. 
 
4.4 Conclusion 
The spray sonocrystallization method produces nanoscaled pharmaceutical molecular 
crystals with a narrow size distribution. Nanocrystal size can be easily controlled through 
solute concentration. Nonionic and anionic surfactants, PVP and SDS, effectively reduce 
aggregation of the nanocrystals. Given the lower ultrasonic power demands necessary for these 
laboratory scale experiments, we have some confidence that one may achieve scale-up to kg 
levels without great difficulty. 
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Chapter 5 
Sonocrystallization of carbamazepine 
 
5.1 Introduction 
It is important to control particle size of pharmaceutical agents since the particle size can 
affect to the solubility and dissolution rate.1-3 Pharmaceutical agents for orally-ingested drugs 
should have not only sufficient lipophilicity to pass through cell membrane but also sufficient 
hydrophilicity to be transported within the body.4-6 If a pharmaceutical agent has low solubility 
in water, transport in blood plasma is difficult and the absorption of the drug into the target 
organ can be problematic.7-9 Therefore, it is crucial to improve the solubility and dissolution 
rate of hydrophobic pharmaceutical agents. 
Reducing the size of a particle increases its solubility by increasing the surface area per 
unit volume.10-17 Dissolution occurs at the interface between the particle and surrounding 
solvent. Therefore, an increased surface area increases the chance of molecules on the surface 
of a particle dissolving in the surrounding solvent. In 1900, Ostwald and Freundlich 
determined the following relationship between salt particle size and solubility18:  
  
where c(r) = solubility of particles of size r; c* = normal equilibrium solubility of the substance; 
M = molar mass of the substance in the solution; γ = interfacial tension of the substance in 
contact with the solution; ν = number of moles of ions formed from one mole of electrolyte; 
R = gas constant; T = absolute temperature; and ρ = density of the substance. 
Decreasing particle size also increases the dissolution rate of the particles.10, 17, 19-22 
According to the Noyes–Whitney equation, the dissolution rate is affected by the surface area 
118 
 
and concentration of the dissolving substance, and by the thickness of the boundary layer of 
solvent around the dissolving substance.23 Noyes and Whitney suggested their relationship 
could be written as: 
 
where m = mass of the dissolving substance; t = time; D = diffusion coefficient of the 
dissolving substance; A = surface area of the dissolving substance; cs = solubility of the 
substance; ct = mass concentration of the substance in the bulk medium at time t; and hD = 
thickness of the boundary layer of the solvent at the surface of the dissolving substance. 
Reducing particle size increases the surface area per unit volume dramatically. In addition, the 
thickness of the boundary layer decreases with reduction of particle size due to the increased 
relative velocity of the flowing solvent against the surface of the particle.24 Consequently, the 
dissolution rate is accelerated as the particle size is reduced. 
Carbamazepine is one of the most essential medications for the treatment of epilepsy, 
neuropathic pain and schizophrenia,25 but it is poorly soluble in water (~125 mg/L at 25 °C).26 
Consequently, the absorption of carbamazepine in the gastrointestinal tract is delayed and 
irregular.8, 27 Studies have examined ways to reduce the crystal size of carbamazepine to 
improve its solubility and dissolution rate. There are only a few reports, however, on 
carbamazepine nanoparticles generated using additives such as polymers or surfactants.28-31 
Without these additives, aggregates of carbamazepine nanoparticles are produced.32 
In this chapter, carbamazepine micro- and nanocrystals were produced by 
sonocrystallization without the use of additives. Also, the carbamazepine crystals were 
generated using evaporation‒cooling and antisolvent crystallization methods. The size, 
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morphology, and structure of the crystals were compared. Finally, it was investigated the effect 
of crystal size on the solubility and dissolution rate of carbamazepine. 
 
5.2 Experimental 
5.2.1 Materials 
Carbamazepine were purchased from Sigma-Aldrich and used as-received, unless 
otherwise indicated. Ethanol (100%) was purchased from Decon Laboratory. For 
crystallization, nanopure water (i.e., water deionized to >18 MΩ·cm resistance, scrubbed for 
organics, and passed through a 0.45 μm filter with a Barnstead NANOpure® ultrapure water 
purification system) was used.  
 
5.2.2 Crystallization of carbamazepine 
5.2.2.1 Evaporation‒cooling crystallization with or without seed crystals 
First, 250 mg of carbamazepine was completely dissolved in 10 mL of ethanol at 60 °C 
and 20 mg of carbamazepine seed crystals (Sigma-Aldrich) were added to the carbamazepine 
solution when it reached 40 °C. The carbamazepine solution was cooled to room temperature 
in a vial that was covered loosely with a cap. Evaporation was completed within about 36 
hours. For evaporation‒cooling crystallization without seed crystals, the procedures were 
same, except no seed crystals were added. 
 
5.2.2.2 Antisolvent crystallization 
Excess carbamazepine was dissolved in 10 mL of ethanol at 25 °C for five hours with a 
magnetic stirring bar and a stirrer (900 rpm) to form a saturated carbamazepine solution. The 
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carbamazepine solution was added to 10 mL of nanopure water at 25 °C with a syringe pump 
(Harvard Apparatus Compact Infusion Pump), at a rate of 9.6 mL/min, through a syringe filter 
(Thermo Scientific Nalgene Syringe Filter, pore size 0.2 μM) with a syringe to prevent the 
injection of undissolved carbamazepine solid into the nanopure water. A magnetic stirring bar 
was used to mix the carbamazepine solution and nanopure water at 900 rpm. After finishing 
the injection, the solid was separated from the liquid by centrifugation and dried in a vacuum 
oven at 25 °C overnight. 
 
5.2.2.3 Antisolvent sonocrystallization 
All of the steps were the same as for antisolvent crystallization, except an exponential 
ultrasonic horn (VCX-750; Sonics and Materials, 20 kHz, 1 cm2 titanium tip, 15 W/cm2) was 
used to sonicate the carbamazepine solution and nanopure water instead of stirring it with a 
magnetic stirring bar. The sonication was done in a temperature-controlled water bath 
(Isotemp 1006S; Thermo Scientific) to prevent significant increase in the temperature of the 
mixed solution. The initial and final temperatures of the mixed solution were 18 and 25 °C, 
respectively. After the injection was complete, the solid was separated from the liquid by 
centrifugation and dried in a vacuum oven at 25 °C overnight. 
 
5.2.2.4 Spray sonocrystallization 
The experimental method for spray sonocrystallization followed our previous report.33 
Excess amount of carbamazepine was dissolved in 10 ml of ethanol at 25 °C to form saturated 
carbamazepine solution. The carbamazepine solution was pumped with a syringe pump 
through a tapped ultrasonic horn (i.e., a hole drilled from top to bottom of the horn, Sonics and 
Materials dual inlet atomizing probe VCX 130 AT, 20 kHz), exiting from the bottom (an 
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acoustic antinode of the horn) into the mixing region of the flow cell into which the antisolvent 
(nanopure water) was also pumped. The carbamazepine solution was pumped through the horn 
with a syringe pump (Harvard Apparatus Compact Infusion Pump), at a rate of 9.6 mL/min. 
A syringe filter (Thermo Scientific Nalgene Syringe Filter, pore size 0.2 μM) was used with 
the syringe to prevent the injection of undissolved carbamazepine solid into the nanopure 
water. The ultrasonic horn was immersed in a flowing antisolvent of nanopure water. The 
initial temperature of nanopure water was set to 18 °C using a water bath; its flow was set to 
48 mL/min using a peristaltic pump (Cole-Parmer Instrument Company MasterFlex 77390-
00). The carbamazepine solution was rapidly dispersed into the antisolvent via momentum 
transfer from the ultrasonic horn. The ultrasonic power delivered by the tapped horn was 
calorimetrically determined and set to 15 W/cm2. Aliquots of the sonicated mixture were 
collected every minute and diluted in 10 mL of nanopure water. For characterization, product 
was collected after a full steady state was reached, specifically after 6 min. 
 
5.2.3 Solubility tests 
Solutions of carbamazepine in ethanol were prepared at concentrations of 0.05, 0.10, 0.15, 
and 0.20 mM. Saturated solutions in 10 mL of deionized (DI) water were prepared by adding 
excess carbamazepine and stirring for 2 days at 25 or 37 °C. The supernatant was filtered 
through a syringe filter (Thermo Scientific Nalgene Syringe Filter, pore size 0.2 μM) to 
remove any carbamazepine particles before UV-Vis analysis. The initially saturated 
carbamazepine solutions were diluted and UV-visible absorption spectra were measured. The 
ultraviolet-visible (UV-Vis) absorption of each solution was measured with a UV-Vis 
spectrometer (Lambda 35; PerkinElmer). The molar absorptivity coefficients were calculated 
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at an absorption peak of 285 nm. The amount of dissolved carbamazepine was calculated based 
on the intensity of the UV-visible absorption peak at 285 nm. 
 
5.2.4 Dissolution tests 
2.2 mg of carbamazepine was added to 10 mL of DI water and stirred with a magnetic bar 
(150 rpm) at 37°C in a silicon oil bath. After the stirring was stopped, the carbamazepine 
solution was filtered through a syringe filter (Thermo Scientific Nalgene Syringe Filter, pore 
size 0.2 μM) to remove any particulate carbamazepine. The filtered solution was diluted and 
the UV-visible absorption was measured by UV-Vis spectrometry (PerkinElmer Lambda 35). 
The amount of dissolved carbamazepine was calculated based on the intensity of the UV-
visible absorption peak at 285 nm. 
 
5.2.5 Characterization 
Optical microscopy was performed with a Zeiss Axioskop optical/fluorescence 
microscope. The micrographs were captures using a Cannon PC1015 digital camera mounted 
to the microscope. Scanning electron microscopy was performed with a JEOL 7000F 
Analytical SEM.  Particle size analysis from SEM images was performed using Image-J 
software (National Institutes of Health, Bethesda, MD, USA). Approximately 200 particles 
were measured for each experiment. Data fitting was performed using OriginPro 8.5 software 
(OriginLab, Northampton, MA, USA). Powder X-ray diffraction patterns were obtained from 
samples mounted on a quartz sample holder using a Bruker D-5000 (λ = 1.5418 Å, 25 °C) in 
the 2 theta range 10-35 theta.  
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5.3 Results and discussion 
5.3.1 Crystallization of carbamazepine 
The different crystallization methods produced carbamazepine crystals with diverse 
morphologies and sizes (Figure 5.1). The carbamazepine crystals from Sigma-Aldrich and 
carbamazepine crystals generated by evaporation‒cooling crystallization with seed crystals 
had random rock shapes. All of the other carbamazepine crystals were needle shaped. The 
average crystal size ranged from 9 to 470 μM (Table 5.1). Antisolvent crystallization, 
antisolvent sonocrystallization, and spray sonocrystallization generated smaller crystals than 
evaporation‒cooling crystallization, because the addition of the antisolvent reduced the 
metastable zone width and induction time, accelerating the rate of nucleation and producing 
many small crystals.34-36 In addition to the antisolvent effect, antisolvent sonocrystallization 
and spray sonocrystallization showed reduction of metastable zone width and induction time, 
increase of nucleation sites, etc.37-38 Consequently, the crystals produced by antisolvent 
sonocrystallization and spray sonocrystallization were smaller than those produced by 
antisolvent crystallization. For spray sonocrystallization, there was enhanced mixing of the 
antisolvent and saturated solution in the spray sonocrystallization system.33 Spray 
sonocrystallization produced the smallest carbamazepine crystals among the five different 
crystallization methods.  
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Figure 5.1 Optical microscopy images of carbamazepine crystals (a) purchased from Sigma-
Aldrich Chemicals and produced by (b) evaporation‒cooling crystallization without the 
addition of seed crystals, (c) evaporation‒cooling crystallization with the addition of seed 
crystals, (d) antisolvent crystallization, (e) antisolvent sonocrystallization, and (f) spray 
sonocrystallization. 
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Table 5.1 Average size of carbamazepine crystals produced by various crystallization methods.  
Method Aldrich 
Chemical 
Evaporation 
(without 
seeds) 
Evaporation 
(with seeds) 
Antisolvent Antisolvent 
sono-
crystallization 
Spray sono-
crystallization 
Average 
crystal 
size (μm) 
36 ± 4 473 ± 6 62 ± 4 73 ± 4 12 ± 1 9 ± 1 
*Carbamazepine crystallization and crystal size analysis were performed twice for each 
method. 
 
5.3.2 Spray sonocrystallization of carbamazepine with different ratios of water to 
carbamazepine solution 
Spray sonocrystallization controlled the size of the carbamazepine crystals, and nano-scale 
crystals could be produced by changing the ratio of water to carbamazepine solution. When 
the ratio was changed from 5:1 to 240:1, the average crystal size of produced crystals was 
changed from about 8 μM to 140 nm (Table 5.2). Figure 5.2 shows that the average crystal 
size decreased exponentially as the proportion of water in the mixture of water and 
carbamazepine solution increased. A solution with a high mixing ratio reached a higher 
supersaturated level and had a more rapid nucleation rate than a solution with a low mixing 
ratio.10, 39 Consequently, in the solution with a high mixing ratio, the total number of crystals 
produced increased and the size of each crystal decreased. 
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Table 5.2 Average size of carbamazepine crystals generated by spray sonocrystallization with 
different ratios of water to carbamazepine solution.  
Mixing ratio 
(Water : CBZ solution) 
5 : 1 10 : 1 21 : 1 37 : 1 60 : 1 120 : 1 240 : 1 
Average crystal size 
(μm) 
8.6±0.5 7.3±0.1 6.3±0.6 2.9±0.5 1.2±0.1 0.5±0.1 0.14±0.01 
* Carbamazepine crystallization and crystal size analysis were performed twice for each 
mixing ratio. 
 
 
Figure 5.2 Relationship between the mixing ratio of water to carbamazepine solution and the 
size of carbamazepine crystals using spray sonocrystallization. For each mixing ratio, spray 
crystallization and crystal size analysis were performed twice. Each point is the average of 
two experimental results and each error bar is the standard deviation of the two results. The 
solid line is the exponential decay fit to the data.  
 
The morphology of carbamazepine changed gradually with the mixing ratio (Figure 5.3). 
The ratio of the length to width of a crystal decreased as the mixing ratio increased: i.e. the 
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morphology changed from needles to rods to spheres. Figure 5.3(g) shows non-agglomerated 
carbamazepine nanocrystals produced by spray sonocrystallization without the use of 
additives. 
 
Figure 5.3 SEM images of carbamazepine crystals generated by spray sonocrystallization with  
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Figure 5.3 (cont.) 
different mixing ratio of water to carbamazepine solution: (a) 5 : 1, (b) 10 : 1, (c) 21 : 1, (d) 
37 : 1, (e) 60 : 1, (f) 120 : 1, and (g) 240 : 1. 
 
5.3.3 Crystal structures of carbamazepine 
The structures of the carbamazepine crystals were confirmed by powder X-ray diffraction. 
There are four different polymorphs of carbamazepine and their order of stability at ambient 
temperature is form III > form I > form IV > form II.40-41 The Sigma-Aldrich carbamazepine 
and carbamazepine generated by evaporation‒cooling crystallization with seed crystals were 
carbamazepine form III (Figure 5.4, left). The carbamazepine generated by evaporation‒
cooling crystallization without seed crystals were carbamazepine form II. Antisolvent 
crystallization, antisolvent sonocrystallization, and spay sonocrystallization produced 
carbamazepine dihydrate because of the addition of water (Figure 5.4, right). 
 
 
Figure 5.4 Powder X-ray diffraction patterns of carbamazepine. (Left) (a) carbamazepine 
form III calculated from single crystal X-ray diffraction data, (b) as-purchased carbamazepine,  
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Figure 5.4 (cont.) 
(c) carbamazepine generated by evaporation‒cooling crystallization with seed crystals, (d) 
carbamazepine form II calculated from single crystal X-ray diffraction data, and (e) 
carbamazepine generated by evaporation‒cooling crystallization without seed crystals. (Right) 
(a) carbamazepine dihydrate calculated from single crystal X-ray diffraction data, (b) 
carbamazepine generated by antisolvent crystallization, (c) carbamazepine generated by 
antisolvent sonocrystallization, and (d) carbamazepine generated by spray sonocrystallization. 
Single crystal data was reported in the Cambridge Structural Database. 
 
5.3.4 Solubility tests 
Various crystallization methods generated three different carbamazepine crystals (i.e., 
form II, form III, and dihydrate), which have different intrinsic solubilities. The intrinsic 
solubilities (i.e., initial solubility) of carbamazepine are in the order form III > form II > 
dihydrate.42-44 The intrinsic solubility of carbamazepine differs from its equilibrium solubility 
(i.e., long-term solubility). Carbamazepine forms III and II are hydrated in an aqueous 
environment becoming carbamazepine dihydrate rapidly.45-46 Therefore, there is no significant 
difference in the equilibrium solubility of form III, form II, and dihydrate. 
The effect of carbamazepine crystal size on its equilibrium solubility was confirmed by 
solubility tests. The solubility tests were performed in water at 25 and 37°C for 2 days, 
respectively. It is assumed the carbamazepine crystals described in Section 5.3.1 and 5.3.2 
were spheres and equivalent diameters were calculated. Although the equivalent diameter of 
the crystals ranged from 51 to 140 nm, their solubility did not differ significantly at 25°C 
(Figure 5.5). At 37°C, the solubility increased slightly as the size of the crystals decreased. 
Therefore, for the size range studied, crystal size had little effect on the equilibrium solubility 
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of carbamazepine. This is not unexpected, since size effect are most important only below 
about 50 nm dimensions. 
 
Figure 5.5 The effect of crystal size on the aqueous solubility of carbamazepine. The solubility 
of each sample was tested three times each at 25 and 37°C. Each point is the average value of 
the three trials and the error bar is the standard deviation. 
 
5.3.5 Dissolution tests 
The dissolution rate of the various sizes and forms of carbamazepine was tested in water 
at 37°C. The dissolution rate increased as the crystal size decreased, since smaller particles 
have a higher surface-area-to-volume ratio (Figure 5.6). Although carbamazepine dihydrate 
crystals, which have the lowest initial solubility among carbamazepine form II, form III, and 
dihydrate, were produced via antisolvent crystallization, antisolvent sonocrystallization, and 
spray sonocrystallization, their dissolution rates were more rapid than the dissolution rate of 
carbamazepine crystals purchased from Sigma-Aldrich or generated by evaporation‒cooling 
crystallization with or without the addition of seed crystals. Therefore, the effect of crystal 
size was more important than the effect of intrinsic solubility in the dissolution tests. 
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Figure 5.6 Dissolution rate of carbamazepine generated (a) by various crystallization methods 
and (b) by spray sonocrystallization with different ratios of water to carbamazepine solution.  
 
The change in crystal size affected the time required to dissolve half of the initial 
carbamazepine (i.e., the half-time). Figure 5.7(a) shows that the half-time decreased with the 
equivalent diameter. According to the Noyes–Whitney equation and Prandtl’s boundary layer 
equation,23-24 the half-time is proportional to the (particle diameter)1.5 when the dissolved 
particle is a sphere. For all samples, however, the half-time was not proportional to the 
(particle diameter)1.5 (Figure 5.7a). In this experiment, the carbamazepine crystals were of 
three different forms (i.e., form II, form III, and dihydrate) and the initial dissolution rates 
were affected by the form of carbamazepine. Due to the different forms of carbamazepine, the 
relationship between the equivalent diameter and half-time did not follow the Noyes–Whitney 
equation and Prandtl’s boundary layer equation. Considering only the carbamazepine 
dihydrate crystals, the half-time was approximately proportional to the (particle diameter)1.5 
(Figure 5.7b). 
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Figure 5.7 Relationship between the equivalent diameter and half-time (a) for all 
carbamazepine samples and (b) for carbamazepine dihydrate. In (b), the data were fitted by 
the exponential function y = a∙x1.5 (a = constant). 
 
5.4 Conclusion 
Five different crystallization methods produced carbamazepine crystals with diverse sizes 
and forms. Among the methods, spray sonocrystallization controlled crystal size 
systematically by altering the mixing ratio between water (the antisolvent) and carbamazepine 
solution. Spray crystallization produced non-agglomerated carbamazepine nanocrystals 
without the use of additives. In the range from several hundred micrometers to one hundred 
nanometers, crystal size had little effect on the solubility in water. The dissolution rate in water, 
however, increased significantly as the crystal size decreased. 
 
5.5 References 
1. Blagden, N.; de Matas, M.; Gavan, P. T.; York, P., Crystal engineering of ac
tive pharmaceutical ingredients to improve solubility and dissolution rates. Advanced 
Drug Delivery Reviews 2007, 59 (7), 617-630. 
133 
 
2. Stahl, P. H.; Wermuth, C. G., Handbook of pharmaceutical salts properties, s
election, and use. John Wiley & Sons: 2008. 
3. Chen, J.; Sarma, B.; Evans, J. M. B.; Myerson, A. S., Pharmaceutical crystall
ization. Crystal Growth & Design 2011, 11 (4), 887-895. 
4. Liversidge, G. G.; Cundy, K. C., Particle size reduction for improvement of 
oral bioavailability of hydrophobic drugs. International Journal of Pharmaceutics 199
5, 125 (1), 91-97. 
5. Amidon, G. L.; Lennernas, H.; Shah, V. P.; Crison, J. R., A theoretical basis
 for a biopharmaceutic drug classification - the correlation of in-vitro drug product di
ssolution and in-vivo bioavailability. Pharmaceutical Research 1995, 12 (3), 413-420. 
6. Balaz, S., Modeling kinetics of subcellular disposition of chemicals. Chemical 
Reviews 2009, 109 (5), 1793-1899. 
7. Fincher, J. H., Particle size of drug and its relationship to absorption and acti
vity. Journal of Pharmaceutical Sciences 1968, 57 (11), 1825-&. 
8. Dressman, J. B.; Amidon, G. L.; Reppas, C.; Shah, V. P., Dissolution testing 
as a prognostic tool for oral drug absorption: Immediate release dosage forms. Pharm
aceutical Research 1998, 15 (1), 11-22. 
9. Lindenberg, M.; Kopp, S.; Dressman, J. B., Classification of orally administer
ed drugs on the World Health Organization Model list of Essential Medicines accordi
ng to the biopharmaceutics classification system. European Journal of Pharmaceutics 
and Biopharmaceutics 2004, 58 (2), 265-278. 
10. Mullin, J. W., Crystallization. Butterworth-Heinemann: 2001. 
134 
 
11. Buckton, G.; Beezer, A. E., The relationship between particle size and solubil
ity. International Journal of Pharmaceutics 1992, 82 (3), R7-R10. 
12. Wu, W. J.; Nancollas, G. H., A new understanding of the relationship betwee
n solubility and particle size. Journal of Solution Chemistry 1998, 27 (6), 521-531. 
13. Iggland, M.; Mazzotti, M., Population balance modeling with size-dependent s
olubility: Ostwald ripening. Crystal Growth & Design 2012, 12 (3), 1489-1500. 
14. O'Mahony, M.; Leung, A. K.; Ferguson, S.; Trout, B. L.; Myerson, A. S., A 
process for the formation of nanocrystals of active pharmaceutical ingredients with po
or aqueous solubility in a nanoporous substrate. Organic Process Research & Develo
pment 2015, 19 (9), 1109-1118. 
15. Enustun, B. V.; Turkevich, J., Solubility of fine particles of strontium sulfate.
 Journal of the American Chemical Society 1960, 82 (17), 4502-4509. 
16. Segets, D.; Gradl, J.; Taylor, R. K.; Vassilev, V.; Peukert, W., Analysis of o
ptical absorbance spectra for the determination of ZnO nanoparticle size distribution, 
solubility, and surface energy. Acs Nano 2009, 3 (7), 1703-1710. 
17. Sun, J.; Wang, F.; Sui, Y.; She, Z. N.; Zhai, W. J.; Wang, C. L.; Deng, Y. 
H., Effect of particle size on solubility, dissolution rate, and oral bioavailability: eval
uation using coenzyme Q(10) as naked nanocrystals. International Journal of Nanome
dicine 2012, 7, 5733-5744. 
18. Ostwald, W., On the assumed isomerism of red and yellow mercury oxide an
d the surface-tension of solid bodies. Zeitschrift Fur Physikalische Chemie--Stochiomet
rie Und Verwandtschaftslehre 1900, 34 (4), 495-503. 
135 
 
19. Kesisoglou, F.; Panmai, S.; Wu, Y. H., Nanosizing - oral formulation develop
ment and biopharmaceutical evaluation. Advanced Drug Delivery Reviews 2007, 59 
(7), 631-644. 
20. Vogelsberger, W.; Schmidt, J., Studies of the solubility of BaSO4 nanoparticl
es in water: kinetic size effect, solubility product, and influence of microporosity. Jou
rnal of Physical Chemistry C 2011, 115 (5), 1388-1397. 
21. Radacsi, N.; Ambrus, R.; Szabo-Revesz, P.; van der Heijden, A.; ter Horst, J.
 H., Atmospheric pressure cold plasma synthesis of submicrometer-sized pharmaceutic
als with improved physicochemical properties. Crystal Growth & Design 2012, 12 (1
0), 5090-5095. 
22. Radacsi, N.; Ambrus, R.; Szunyogh, T.; Szabo-Revesz, P.; Stankiewicz, A.; v
an der Heijden, A.; ter Horst, J. H., Electrospray crystallization for nanosized pharma
ceuticals with improved properties. Crystal Growth & Design 2012, 12 (7), 3514-352
0. 
23. Noyes, A. A.; Whitney, W. R., The rate of solution of solid substances in th
eir own solutions. Journal of the American Chemical Society 1897, 19 (12), 930-934. 
24. Prandtl, L., Verhandlungen des dritten internationalen Mathematiker-Kongresse
s. Heidelberg, Leipeizig 1904, 484-491. 
25. WHO Model Lists of Essential Medicines. (accessed http://www.who.int/medici
nes/publications/essentialmedicines/en/). 
26. Shayanfar, A.; Velaga, S.; Jouyban, A., Solubility of carbamazepine, nicotina
mide and carbamazepine-nicotinamide cocrystal in ethanol-water mixtures. Fluid Phase
136 
 
 Equilibria 2014, 363, 97-105. 
27. Bertilsson, L., Clinical pharmacokinetics of carbamazepine. Clinical Pharmaco
kinetics 1978, 3 (2), 128-143. 
28. Wang, M.; Rutledge, G. C.; Myerson, A. S.; Trout, B. L., Production and ch
aracterization of carbamazepine nanocrystals by electrospraying for continuous pharma
ceutical manufacturing. Journal of Pharmaceutical Sciences 2012, 101 (3), 1178-1188. 
29. Kumar, R.; Siril, P. F., Ultrafine carbamazepine nanoparticles with enhanced 
water solubility and rate of dissolution. Rsc Advances 2014, 4 (89), 48101-48108. 
30. Tummala, S.; Satish Kumar, M.; Prakash, A., Formulation and in vitro charac
terization of carbamazepine polymeric nanoparticles with enhanced solubility and susta
ined release for the treatment of epilepsy. J Chem Pharm Res 2015, 7, 70-79. 
31. Ueda, K.; Higashi, K.; Yamamoto, K.; Moribe, K., In situ molecular elucidati
on of drug supersaturation achieved by nano-sizing and amorphization of poorly wate
r-soluble drug. European Journal of Pharmaceutical Sciences 2015, 77, 79-89. 
32. Duarte, I.; Corvo, M. L.; Serodio, P.; Vicente, J.; Pinto, J. F.; Temtem, M., 
Production of nano-solid dispersions using a novel solvent-controlled precipitation pro
cess - Benchmarking their in vivo performance with an amorphous micro-sized solid 
dispersion produced by spray drying. European Journal of Pharmaceutical Sciences 2
016, 93, 203-214. 
33. Kim, H. N.; Sander, J. R. G.; Zeiger, B. W.; Suslick, K. S., Spray sonocryst
allization. Crystal Growth & Design 2015, 15 (4), 1564-1567. 
34. Reverchon, E., Supercritical antisolvent precipitation of micro- and nano-partic
137 
 
les. Journal of Supercritical Fluids 1999, 15 (1), 1-21. 
35. D'Addio, S. M.; Prud'homme, R. K., Controlling drug nanoparticle formation 
by rapid precipitation. Advanced Drug Delivery Reviews 2011, 63 (6), 417-426. 
36. Chan, H. K.; Kwok, P. C. L., Production methods for nanodrug particles usin
g the bottom-up approach. Advanced Drug Delivery Reviews 2011, 63 (6), 406-416. 
37. de Castro, M. D. L.; Priego-Capote, F., Ultrasound-assisted crystallization (son
ocrystallization). Ultrasonics Sonochemistry 2007, 14 (6), 717-724. 
38. Sander, J. R. G.; Zeiger, B. W.; Suslick, K. S., Sonocrystallization and sonof
ragmentation. Ultrasonics Sonochemistry 2014, 21 (6), 1908-1915. 
39. Beckmann, W., Crystallization: basic concepts and industrial applications. Joh
n Wiley & Sons: New York, 2013. 
40. Grzesiak, A. L.; Lang, M. D.; Kim, K.; Matzger, A. J., Comparison of the f
our anhydrous polymorphs of carbamazepine and the crystal structure of form I. Jour
nal of Pharmaceutical Sciences 2003, 92 (11), 2260-2271. 
41. Rustichelli, C.; Gamberini, G.; Ferioli, V.; Gamberini, M. C.; Ficarra, R.; To
mmasini, S., Solid-state study of polymorphic drugs: carbamazepine. Journal of Phar
maceutical and Biomedical Analysis 2000, 23 (1), 41-54. 
42. Lowes, M. M. J.; Caira, M. R.; Lotter, A. P.; Vanderwatt, J. G., Physicoche
mical properties and x-ray structural studies of the trigonal polymorph of carbamazepi
ne. Journal of Pharmaceutical Sciences 1987, 76 (9), 744-752. 
43. Murphy, D.; Rodriguez-Cintron, F.; Langevin, B.; Kelly, R. C.; Rodriguez-Hor
nedo, N., Solution-mediated phase transformation of anhydrous to dihydrate carbamaze
138 
 
pine and the effect of lattice disorder. International Journal of Pharmaceutics 2002, 
246 (1-2), 121-134. 
44. Sehic, S.; Betz, G.; Hadzidedic, S.; El-Arini, S. K.; Leuenberger, H., Investig
ation of intrinsic dissolution behavior of different carbamazepine samples. Internationa
l Journal of Pharmaceutics 2010, 386 (1-2), 77-90. 
45. Kobayashi, Y.; Ito, S.; Itai, S.; Yamamoto, K., Physicochemical properties an
d bioavailability of carbamazepine polymorphs and dihydrate. International Journal of 
Pharmaceutics 2000, 193 (2), 137-146. 
46. Tian, F.; Zeitler, J. A.; Strachan, C. J.; Saville, D. J.; Gordon, K. C.; Rades, 
T., Characterizing the conversion kinetics of carbamazepine polymorphs to the dihydr
ate in aqueous suspension using Raman spectroscopy. Journal of Pharmaceutical and 
Biomedical Analysis 2006, 40 (2), 271-280. 
 
 
